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Abstract 
 
Several of the plants which are currently being used in fish feed in Norway today, are being 
genetically modified (GM) around the world. The use of GM plants is increasing worldwide, 
and whether these are safe to use in fish feed has been questioned. Deoxynivalenol (DON) is a 
highly prevalent mycotoxin contaminant found in crops. Previous findings suggest that GM 
maize has a higher level of this contaminant. This study aims to investigate whether GM 
maize (event MON 810) and low DON contamination affects performance, intestinal mRNA 
and white blood differentiation when fed to Zebrafish (Danio rerio).  
Two separate trials were run simultaneously; (1) zebrafish were fed either GM maize (event 
MON 810) or the conventional near-isogenic parental line for 45 days, (2) zebrafish were fed 
diets with increasing concentration of synthetic DON (0.0, 0.1, 0.5, 1.5, 2, 3 ppm DON) for 
45 days. All fish were weight and measured when terminated. The intestine was analyzed for 
difference in gene expressions using Quantitative Real Time RT PCR (qPCR), and white 
blood cell differentiation was performed on blood samples.  
Feed acceptance was good for both trials. The fish fed GM maize had a higher growth than 
the non-GM group, although this increase was not significant. There fish feed 0.1 ppm DON 
had the highest growth for the DON trial, however there were no significant differences 
between the diets. No significant differences was observed for the mean normalized gene 
expressions (MNE) for the maize diets, although there was a trend towards increase of 
mitogen activated protein kinase (Mapk14) which could indicate ribotoxic stress. The MNE 
for the DON trial showed no significant difference or dose response to the increased DON 
concentrations in the diets. No effects were observed for the white blood cell differentiation 
for either of the trials. 
In conclusion, an inclusion level of 19 % GM maize does not significantly affect fish 
performance, intestinal mRNA or white blood cell differentiation in zebrafish. Low 
concentrations of naturally contaminated or synthetically DON do not seem to affect zebrafish 
growth, intestinal mRNA transcript levels or white blood cell differentiation. The lack of 
effects indicates, compared to other investigated animals, that zebrafish is not very sensitive 
to DON contamination if feed.  
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1. Introduction 
 
1.1 Genetically modified (GM) plants in aquaculture 
 
During the last two decades the world of agriculture has encountered huge changes including 
introduction of genetically altered plants. The commercial use of genetically modified (GM) 
plants was initiated in 1996, and has increased each year since (James, 2011).  
 
Figure 1.1: The graph show the cultivation increase (millions hectares) of GM maize in different areas (GMO-
Compass, 2010), whilst the pie chart show how much of the total maize production is GM plants (James, 2012). 
Organisms that have been genetically altered are collectively known as Genetically Modified 
Organisms (GMO).  The Norwegian Gene Technology act from 1993 states that GMOs are 
“microorganisms, plants and animals whose genetic material has been altered using gene 
technology providing a gene combination that could not occur  naturally or by mutations  in 
nature” (lovdata, 2001). Today, the main GM plants are soybeans, maize, canola and cotton 
grown in 29 countries with USA, Brazil, Argentina and India being the four largest producers 
(James, 2012). The rapid increase in aquaculture production, along with intensification of the 
production cycle has created a great need for ingredients for fish feed (Watanabe, 2002, FAO, 
2010). Carnivore fish such as salmon (Salmo salar) has traditionally been feed fish meal and 
fish oils from wild caught fish. However, the increased requirement of an intensified industry 
puts a strain on the reservoirs of the wild fish used for fish meal and fish oil production.   
 
GM maize 32 
% Conventional 
maize 68 % 
Total area of maize production 
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Alternatives to traditional feed ingredients have been investigated for several years, and the 
three main fish feed producers in Norway incorporates both marine and plant ingredients into 
their products. In 2010, Skretting reported a fish meal inclusion of only 15 %, and the marine 
ingredients were only 50 % in the equivalent feed from EWOS. Biomar has even established 
its own sustainability program to ensure that only sustainable ingredients are being used 
(Ewos, 2011, Skretting, 2010, Biomar). 
Experiments on replacing fish meal with plant protein have shown that it is possible to almost 
entirely replace fish meal with plant protein as long as amino acids are balanced to meet the 
nutritional requirements of the species in question (Espe et al., 2006, Torstensen et al., 2008). 
The experiment by Torstensen et al. (2008) showed that the aquaculture industry could be a 
net producer of protein. Even though a high amount of plant protein gave a reduction in 
growth, by replacing 80 % of the fish meal with plant protein the salmon produced 2 kg 
protein per kg fish meal fed which is four times more efficient that diets where the protein 
source is 100 % based on fish material.  
If today’s development continues, will the future of aquaculture probably rely equally as 
much on agriculture, including plants obtained from genetic engineering, as wild fish 
populations.  
1.2  What is genetic engineering  
 
 The amount of GM plants in production is increasing rapidly. Even though new and 
improved techniques are emerging continuously there are still some basic principles that 
apply for general gene modification. Initially the gene coding for the wanted trait has to be 
located and isolated. The gene code is cultured and a marker gene is attached. Thereafter the 
target and marker gene is injected into the DNA of the objects that is to be modified. The new 
DNA is placed in the cell, and by utilization of the marker gene the cell are controlled to 
ensure positive transformation (Peel, 2001). Unsuccessfully transformed cells are eliminated 
and new plants are regenerated from the single transformed cell. When the transformation is 
successfully completed the new transgenic plant is tested for its new trait and can from then 
on be bred conventionally (Stella G, 2000, Christou, 1996). 
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1.2.1 Gene transformation methods 
The plant pathogen Agrobacterium tumefaciens causes crow-gall tumors upon infection of 
dicotyledonous plants (Hoekema et al., 1983).  The large tumor inducing plasmid (Ti plasmid) 
is the causative agent creating the crow-gall tumors which contains Transfer-DNA (T-DNA) 
(Hoekema et al., 1983).  Gene transfer using Agrobacterium tumefaciens quickly became 
popular after it was proven a successful method of transferring full length genes expressing 
antibiotic resistance into tobacco plants by Barton et al. (1983), the method however had its 
limitations (Christou, 1996).  Agrobacterium tumefaciens worked well when introducing new 
genes to the dicotyledonous plants, nonetheless, because of its host specificity the results on 
monocotyledonous plant ( maize, rice wheat, etc.) remained absent (Corbin and Klee, 1991).  
Years later, in 1988, a new method was introduced using high velocity micro projectiles to 
transport substances into cells.  The biolistic method is based on a mechanism that can 
accelerate small tungsten particles to high velocity, making them able to cross cell walls 
(Klein et al., 1987, Klein et al., 1988). An important step in this procedure is that the 
bombarded cell survives and the micro particle can be transported by the cytoplasmic stream. 
Klein et al. (1987) showed that large RNA and DNA could be bound to the small tungsten 
particles (4µm), and therefore being able to successfully delivering biologically active RNA 
and DNA into the cells. The figure below shows a simplified illustration of the two methods 
for gene transformation.  
 
 
Figure 1.2: The picture illustrates the basic principles of the  two main ways of gene modification which are 
described above (Peel, 2001).  
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1.3 Genetically modified maize (event MON 810) and Cry1Ab 
 
The main purposes for genetically modifying maize have been focused around agronomic 
interest with insect resistance as the most common (Christou, 1996). Bacillus thuringensis-
maize (Bt-maize) is a commercially available GM maize (Betz et al., 2000) created by micro 
projectile bombardment. The abbreviation Bt refers to the soil bacterium Bacillus 
thuringensis. This particular bacterium produces cry-proteins during its sporulation phase that 
is toxic to insects of the Lepidoptera, Diptera and Coleoptera species. The European corn 
borer, Ostrinia nubilalis, (EBC) belongs to the Lepidoptera species and is a commercially 
significant pest in maize agriculture (Koziel et al., 1993).  Koziel et al (1993) showed that by 
incorporating the maize DNA with a synthetic gene that coded for the cry1Ab protein derived 
from the B. thuringiensis the maize could produce the toxic cry-protein. During field trials the 
hybrid line (elite inbred plants crossed with traditional lines) showed successful insect 
protection (Armstrong et al., 1995).  Cry1Ab proteins bind to specific receptors in the corn 
borer’s intestine, invading the cell membrane which then disintegrates (Shimada et al., 2006). 
Bt -maize is approved for use in several countries today, with the assumptions of it being 
target specific (Mcclintock et al., 1995) and only able to bind to the EBC intestine. The event 
MON810 produced by Monsanto was approved within the EU both as food and food additives 
and feed and feed additives in 1998, whilst it was approved as early as 1996 in the US 
(CERA, 2009).  However, a study by Chowdhury et al. (2003) showed trace amounts of 
cry1Ab protein in the gastrointestinal contents of pigs feed GM maize.  
Based on these findings, Shimada et al. (2006) investigated the effects of cry1Ab protein on 
bovine, porcine and human intestinal cells. The study showed that even though the cry1Ab 
protein could slightly bind to the brush boarder membrane the toxin had no adverse effects on 
the cells, supporting the initial theory that the cry 1Ab toxin is not harmful to other species, 
although indicating that cry1Ab can bind to other intestines than the ECB. Great concern has 
also been raised around the larvae of the monarch butterfly, Danaus plexippus, since they are 
closely related to the ECB. In enclosed laboratory experiments the monarch butterfly larvae 
showed a slight effect to the cry1Ab toxin from the event mon810 (Hellmich et al., 2001), but 
the levels in the laboratory where much higher than what would occur in nature (Hellmich et 
al., 2001, Anderson et al., 2004).  
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The knowledge gaps connected to the cry proteins and their potential risks of inducing 
adjuvant effects and possibly increase the intestinal permeability has resulted in a new health 
risk evaluation of cry proteins (VKM, 2012).  
1.4 Genetically modified maize (event MON 810) in fish feed 
 
Although several studies have aimed to investigate potentially adverse effects of GM maize as 
animal feed, few studies have focused on GM maize as an ingredient in fish feed (Sissener et 
al., 2011b). Sissener et al. (2011b) summarizes the fish feeding trials with GM products 
including GM maize (MON 810) that has been published in scientific literature. The first trial 
was performed using Atlantic salmon (Salmo salar L.) in an 8 month study. The study 
concluded that, at an inclusion level of 6 % GM (MON 810) , there was no apparent adverse 
effect of feeding GM-maize compared to traditional maize ingredients regarding growth, 
intestinal health and nutritional factors (Sanden et al., 2005, Sanden et al., 2006, Bakke-
McKellep et al., 2008). A shorter study of 82 days, also performed with salmon, with 
increased inclusion levels from 15 to 30 % GM maize resulted in reduced feed intake and 
growth whilst there was an increase in liver size and distal intestinal mass. There were also 
observed increased activity of CuZnSOD in both liver and distal intestine, whilst there was a 
reduction in catalase (CAT) activity in the liver (Sagstad et al., 2007). There was an increase 
of maltase activity in the mid- and distal intestinal segment and increased glucose uptake in 
the pyloric caeca (Hemre et al., 2007). An interesting increase in granulocyte level was also 
observed in the fish fed GM maize (Sagstad et al., 2007). Increased CuZnSOD gene 
expression was also observed in zebrafish (Danio rerio) liver by Sissener et al. (2010). 
However, growth was increased for the GM feed group.  
The research on GM maize on fish is inconclusive both regarding cause and effect, and safety 
of one GM event does not necessarily extrapolate to others. Further investigating the 
deviating results, Sissener et al., (2011a) analyzed the GM maize form the Sagstad et al., 
(2007) trial and found that the levels of the mycotoxin deoxynivalenol (DON)  was much 
higher in the GM maize ingredient creating a possible explanation for the observed effects of 
the fish fed the GM maize feed suggesting that more knowledge is required on the effect of 
low mycotoxin contamination in feed in order to distinguish these from potential GM effects.  
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1.5 Mycotoxin contamination in plants 
 
Mycotoxins are secondary metabolites of fungi as they appear to have no effect on the growth 
or development of the fungi as described by Pitt (1996). Their presence is estimated to have 
occurred for as long as crops have been grown, while occurrence was first determined in the 
early 1960s (Richard, 2007). Initially, the toxins were considered only a storage phenomenon 
where molding caused by incorrect storage was thought to be the reason.  
Updated knowledge shows that several of the mycotoxins can be formed during the growing 
phase of the crops in the field (Richard, 2007). Large variability in mycotoxins is observed 
between locations and growing seasons both in GM and non-GM maize. The general trend is 
however, reduced levels of mycotoxins in Bt -maize compared with conventional maize 
varieties, due to better resistance against Fusarium spp. resulting in limited insect damage to 
the plant (Bakan et al., 2002, Papst et al., 2005, Dowd, 2000, Munkvold et al., 1997). The 
effect of the toxins on humans and animals can be both acute and chronic with toxicities 
ranging from death to deleterious effects upon the central nervous, cardiovascular and 
pulmonary systems, and upon the alimentary tract (Bennett and Klich, 2003). Mycotoxins 
may also be carcinogenic, mutagenic, teratogenic and immunosuppressive (Smith et al., 
1995). Amongst the mycotoxins, aflatoxins have received the greatest attention. Aflatoxin B1 
is the most potent hepato carcinogen known and is also known to have caused acute poisoning 
with fatal outcomes (Pitt et al., 2000). Although several of the other mycotoxins are not as 
toxic, they are much more prevalent that aflatoxins. Deoxynivalenol (DON) is a trichothecene 
mycotoxins produced by species in the fusarium spp (Vesonder et al., 1973) and is one of the 
most common contaminants of wheat, maize and barley worldwide (Rotter, 1996, Bretz et al., 
2006). Out of 200 randomly collected field samples in southern Europe were 139 positive for 
DON contamination with levels ranging from 0.253 to 3.14 ppm (mg/kg) (Griessler et al., 
2010). 
1.6 Deoxynivalenol 
 
The growth of the fusarium species is associated with weather conditions, and the growth of 
DON favors cold and wet surroundings both in field and storage (Vesonder et al., 1973).  
Generally, lower levels of mycotoxins are found in Bt -maize, although regarding DON 
specifically, the relationship is not so clear (Ostry et al., 2010).  
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Analysis of several Bt -maize batches here at NIFES show increased DON in Bt -maize, but 
the variability is large (unpublished data).  
When DON was discovered it was initially named vomitoxin based on the effect it had on 
swine fed contaminated feed. Pigs would refuse to eat the contaminated crops, and vomit 
when ingesting small amounts (Vesonder et al., 1973). Research shows that swine is highly 
sensitive to DON exposure, where consumption of 1-10 ppm causes decreased feed intake, 
reduced growth and impartment of the nutritional efficiency (Rotter, 1996, Young et al., 
1983).  
There have also been reports of changes is blood parameters in pig feed contaminated feed, 
although these changes are difficult to separate from the decreased feed intake and nutritional 
status (Young et al., 1983). Rotter et al. (1994) examined leucocyte level after feeding low 
doses of DON to swine and found that leucocyte level increased after one week, and 
decreased after 28 days for the diet containing 3 ppm DON.  
In general, there are great differences between sensitivity both among species and specific life 
stages, commonly the animals are arranged by decreasing sensitivity as  pigs > mice > rats >> 
poultry ≈ ruminants (Rotter, 1996, Richard, 2007).  
There is a lack of knowledge regarding the effects of DON on aquatic animals as plant 
ingredients have traditionally not been used in feed for aquacultured animals. Recently an 
experiment by Hooft et al. (2011) showed  that aquatic animals can be extremely sensitive. 
Rainbow trout (Oncorhynchus mykiss) fed concentrations of 0.3 – 2.6 ppm naturally 
contaminated DON showed decreased feed intake, reduced growth and lower feed efficiency 
with increasing DON concentration. There has also been an experiment with rainbow trout 
earlier which also states that this specie is highly sensitive to DON contamination (Woodward 
et al., 1983).  
In addition to feed refusal, DON has been reported to cause reduction in tissue protein 
synthesis in kidneys, spleen and ileum of pigs, while no effects were observed in the liver, 
pancreas, duodenum or jejunum (Danicke et al., 2006).  Reduced protein synthesis and 
inhibition of RNA and DNA at the ribosomal level are established effects of DON (Rotter, 
1996, Robbana‐Barnat et al., 1987, Kouadio et al., 2005).  Kouadio et al. (2005) reported of 
alterations in the cell membrane permeability and structure in in vivo experiments with human 
intestinal cells.  
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The immune system is sensitive to DON-induced immunosuppression which arises from the 
vulnerability of the continually proliferating cells that participate in immune–mediated 
activities (Oswald et al., 2005).  
Vaccine immunity is also lowered by DON which could have huge implications for 
vaccination effects in combination with feed contamination (Pinton et al., 2008). DON can 
also affect the mitochondrial metabolism through succinate dehydrogenase activity, which is a 
key enzyme in aerobic energy production in both eukaryotic and prokaryotic cells (Oyedotun 
and Lemire, 2004).   
Cytotoxic effects were also found when investigating the effects on DON on different fish cell 
cultures (Pietsch et al., 2011).  Reactive oxygen species (ROS) was reduced in all cell lines, 
even though there were distinct differences among species which illustrates that even amongst 
fish there is great difference in susceptibility.   
1.7 Risk evaluations of GM feed ingredients and zebrafish as a 
model 
 
Risk evaluations of GM feed ingredients must consider several elements, one being the 
question of substantial equivalence. Substantial equivalence relates to any unintended 
effect(s) introduced by the process of genetic engineering (Aumaitre, 2002). When 
performing risk evaluations of GM feed ingredients, near-isogenic lines are generally 
recommended as the non-GM control. However, there is no perfect control as shown by 
previous studies with differences in e.g mycotoxin levels between GM and the near-isogenic 
control line. When unintentional differences are present, where some may be due to the 
modification and others may be due to storage conditions or production it is challenging to 
interpret the cause of the observed differences in animals fed these plants. It is therefore 
always the investigators responsibility and challenge to try to distinguish between effects that 
are related to the modification and effects that are related to e.g storage conditions or 
production.  
The zebrafish (Danio rerio)  is a teleost which belongs to the Cyprinidae family which has 
been a successful model for studying vertebrate development for a long time (van der Sar et 
al., 2004). Zebrafish was initially used by developmental biologist as a model organism, 
however the advantages of the zebrafish has become apparent to other scientific areas 
including toxicology in more recent time (Hill et al., 2005).  
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The advantages of this fish, compared to other popular research animals like rodents and 
bigger fish, is that the small zebrafish reduces cost both regarding husbandry and feed 
amount. Having a sequenced genome has contributed to establishing the zebrafish as an 
adequate genetic model and has shown several examples of the structural and functional 
conservation of genes across all vertebrates. Despite its small size, analysis of the whole 
organ, tissue, or the intact organism is possible (Hernández and Allende, 2008). Regardless of 
its popularity, there are few studies investigating the nutritional requirements of zebrafish 
(Drew et al., 2008, Sissener et al., 2010, Gomez-Requeni et al., 2010). In the present study, 
the zebrafish were selected to evaluate dietary risks of GM maize (cry1Ab) and DON on 
zebrafish performance, mid intestine gene expressions and the white blood cell population. 
Our model may pinpoint if DON could be a confounding factor when performing GM feeding 
trials.  
 
1.8 Mid-intestinal gene expression 
 
Table 1.1 shows the ten genes that were selected to evaluate the differences in mid-intestine 
gene expressions for the fish. It also gives a brief explanation to the choice of each specific 
gene, which are based either on general knowledge concerning the regulatory effects of the 
gene or direct findings in previous trials with either GM maize or DON contamination.  
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Table 1.1: The different genes selected to evaluate intestinal health of the zebrafish. 
Gene 
 
Reaction mechanisms and previous finding 
Cyclin G1 Controls cell progression in the cell cycle. Can be changed by alterations in growth parameters. Inhibition 
negatively regulates cell progression.  
 
Proliferating cell nuclear antigen  The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The 
encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA 
replication. 
 
Apoptosis-related cysteine peptidase Caspase 6  Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves poly (ADP-ribose) 
polymerase in vitro, as well as lamins.  
 
Interleukin 6 receptor  Deoxynivalenol contamination is linked to an up regulation of pro-inflammatory cytokines which could inhibit 
cytokine signaling and effect growth. 
 
Cytochrome P450, family 1, subfamily A  A detoxification marker connected to phase 1 response. Induction of cyp1A can provide an early warning marker 
of exposure toxic pollutants. 
 
Solute carrier family 5 (Na/glucose cotransporter), 
member 1 
There was an increased glucose uptake in salmon feed GM maize (Hemre et al., 2007). 
maltase-glucoamylase Higher maltase enzyme activity was observed in (Hemre et al., 2007) where they used GM maize. 
Danio rerio ghrelin/obestatin preprohormone  Ghrelin regulated appetite which is one of the major effects of deoxynivalenol contamination in feed. 
Mitogen-activated protein kinase 1  Many natural toxins that inhibit translation such as DON are also effective activators of MAPKs via a 
mechanism known as ribotoxic stress. 
 
Copper zinc superoxide dismutase  Belongs to enzymes that catalyze the dismutation of superoxide into oxygen and hydrogen peroxide, making 
them important antioxidant defense in nearly all cells exposed to oxygen. 
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1.9 Aims of study 
 
This study aims to distinguish between primary (cry1Ab) and secondary factors (DON) found 
in the GM maize feed ingredient by investigating: 
1) If GM maize (event MON810) containing both factors (cry1Ab and naturally contaminated 
DON) is as safe as conventional maize when fed to zebrafish for 45 days by evaluating fish 
performance, intestinal mRNA levels and differential counts of the white blood cell 
population 
2) If there is any dose-response effects of synthetic DON when fed to zebrafish for 45 days by 
evaluating fish performance, intestinal mRNA levels and differential counts of the white 
blood cell population 
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2. Materials and method 
2.1 Animal experiment 
 
The animal experiment was carried out at the Zebrafish laboratory facilities at the National 
Institute of Nutrition and Seafood research (NIFES).  Zebrafish (Danio rerio) (figure 2.1) was 
of the inbreed strain AB wild type reared in the experiment facilities upon starting trial. The 
trial was approved by FDU (approval number ID 2426). 
 
 
Figure 2.1 Zebrafish (Danio rerio) used for the present trial (fichchannel.com, 2010) 
 
2.1.1 Experimental design 
The experiment was carried out in AHAB multiple rack zebrafish system (Aquatic habitats, 
Aauatic Eco-Systems, Apoka, USA). Reverse osmosis and automatic salt adding was used to 
treat the intake water. Filtration was done by UV, mechanical and carbon-filter. Temperature, 
salinity and oxygen was registered every day and measured 28.5 ±0.5 °C, 500 ± 30µS/cm and 
above 90 % respectively.  Photoperiod was 14 light:10 dark.  
Bt -maize feeding trial 
A total of 60 larvae were included in the Bt-maize feed trial. Prior to the trial initiation the fish 
were weighted and divided into two groups where one was fed GM maize and the other fed 
the equivalent near-isogenic line. Each diet consisted of tree individual 3 liter tanks (n = 3). 
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DON feeding trial  
351 Zebrafish larvae were divided into six different groups. Each group was feed one of six 
diets only differing in the amount of added synthetic deoxynivalenol (DON).  
Control (n=4); <20 µg/kg DON, low (n=4); 108 µg/kg DON, medium (n=5); 534 µg/kg DON, 
medium high (n=5); 1543 µg/kg DON, high (n=4); 2002 µg/kg don and high high (n=5); 3022 
µg/kg don. The water supply for the control group was separated from the other in case of any 
leakage of DON from the feed into the water. All groups were kept in 1,5 liter tanks.  
 
  
 
  
 
16 
 
2.2 Feed ingredients and diets 
 
Prior to feed preparation, the Bt-maize and the conventional hybrid line were analyzed for 
mycotoxins at the premier analytical services in London by liquid-mass spectrometry (LC-
MS). The results are presented in Table 2.1.  
Table 2.1 The amount of mycotoxins (µg/kg) in the two different maize ingredients (GM maize and non GM 
maize).  
 
          Toxin 
       Amount (µg/kg) 
GM maize Non GM maize 
Deoxynivalenol (DON) 769 39 
Aflatoxin B1 <0.1 1.8 
Aflatoxin B2 <0.1 0.1 
Nivalenol (NIV) <10 10 
Fumonisin B1 22 114 
Fumonisin B2 <10 22 
Fumonisin B3 <10 15 
Zearalenone (F2, ZON, ZEA)   8.5 <3.0 
 
The diets were produced in laboratories at NIFES. The diet production is based on the mixing 
of three different fractions. The gelatin/carophyll pink was dissolved in hot water (≈80°C) at a 
9:1 ratio (water: gelatin, w/w) before all the dry ingredients and the oil mixture were carefully 
added. The feed blend was mixed in a conventional kitchen machine until homogenous. For 
the DON diets was Deoxynivalenol (Sigma Life Science, St Louis, MO, USA) dissolved in 
water and added to the gelatin/carophyll pink solution. The feed paste was poured onto a 
labeled baking paper covered tray and then dried at low temperatures (40°C) in an oven 
before it was grinded sieved and stored at -18 ºC. Maize was used as the main source of starch 
in the Bt-maize trial with an inclusion level of 19%.  Dextrin was used as the main source of 
starch in the DON trial with an inclusion level of 16%. Table 2.2 and 2.3 shows the 
ingredients for the Bt-maize feed trial and DON trial, respectively.  
  
 
  
 
17 
 
Table 2.2: The approximate composition of the experimental diets containing GM maize and non-GM maize. 
The specification of each ingredient is listed in appendix I.  
Ingredients Composition (%) 
Casein sodium salt 40 
Gelatin 12 
Cod liver oil 3 
Rapeseed oil 9 
Maize 19 
Dextrin 4 
Lecithin 2 
Mineral mix 5 
Vitamin mix  1 
Aminoacid mix 1 
Astaxanthin 1 
Betain 0 
cellulose 3 
Analyzed 
 Crude Protein 53 
Crude Fat 13 
Starch 16 
Total carbohydrates  23 
  
  
  Table 2.3 The approximate composition of the experimental diets containing increasing amounts of 
deoxynivalenol. The specification for each ingredient is listed in appendix I. 
Ingredients Composition (%) 
Casein sodium salt  43 
Gelatin 12 
Cod liver oil 3 
Rapeseed oil  9 
Dextrin 16 
Cellulose 5 
Lecithin 1 
Mineral mix 5 
Vitamin mix  1 
Amino acid mix 1,4 
Astaxanthin 1 
Deoxynivalenol mg kg 
-1
 (ppm)  0, 0.1, 0.5, 1.5, 2.0, 3.0 
Betain 1 
Sucrose 1 
Analyzed 
 Crude Protein 56 
Crude Fat 13 
Starch 17 
Fiber 5 
Analyzed 93 
Not analyzed rest 7 
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2.2.1 Trichothecen in the feed  
The feed samples were analyzed at the veterinary institute using gas Chromatography-mass 
spectrometry (GC-MS) according to the method of Langseth et al. (1998) with only minor 
changes. The whole sample was ground and homogenized. 25 g was extracted with 125 ml 
acetonitrile-water (84+16, v/v) for one hour, followed by purification on a Mycosep 225 
column (Romer Labs, Whashington, USA). A 3 ml aliquot, corresponding to 0.6 g of the 
sample, was evaporated to dryness, and derivatised with pentafluoropropionic anhydride 
(PFPA). The MS was operated in electron impact (EI) mode, measuring 1-3 ions per 
compound in selected ion monitoring (SIM) mode. The trichothecenes nivalenol (m/z 896), 
deoxynivalnol (DON)(m/z 734), HT-2 toxin (m/z 555and 572) and T-2 toxin (m/z 407, 452, 
468). The values given in the brackets are the ions of measurement of each toxin. Two 
internal standards were added to the extracts after purification to compensate for variation in 
the instrument response during the run. The internal standards that were used were fusarenon-
X (for DON and NIV) and neosolaniol (for HT-2 and T2). 
An external standard calibration curve was used for quantification. The detection limit was 
20-30 µg/kg for the toxins. Table 2.4 and 2.5 shows the amount of DON, HT-2, NIV and T2 
for the experimental diets for the Bt –maize feeding  trial and DON fedding trial, respectively.  
Table 2.4 The amount, µg/kg, of the mycotoxins Deoxynivalenol (DON), HT-2 toxin, Nivalenol (NIV) and T2 
toxin in the two experimental diets.  
 
      Feed 
                            Mycotoxin ( µg/kg) 
DON HT-2 NIV T2 
GM maize   80 <20 <30 <30 
Non GM maize <20 <20 <30 <30 
 
Table 2.5 The amount, µg/kg, of the mycotoxins Deoxynivalenol (DON), HT-2 toxin, Nivalenol (NIV) and T2 
toxin in the diets containing increasing amounts of DON.  
 
Diet 
                             Mycotoxin ( µg/kg) 
DON HT-2 NIV T2 
1 <20 <20 <30 <30 
2 118 <20 <30 <30 
3 534 <20 <30 <30 
4 1543 <20 <30 <30 
5 2002 <20 <30 <30 
6 3022 <20 <30 <30 
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2.2.2 Feeding  
The fish were fed twice every day, where first feeding was within the first hour of light and 
the second around eight hours later. The quantity of feed given to each tank was weighted 
each day to carefully control that all the groups had been given the same amount of feed. The 
fish were monitored during feeding to detect any difference in appetite between the groups. 
During the first weeks of the trial the larvae were fed approximately 10 % of their body mass 
based on the mean starting weight and estimated growing rate for zebrafish. The feed quantity 
was gradually reduced to 2-3 % of body mass at the end of the trial. Feed particle size was 
gradually increased from 315-400 µm to 560-700 µm at the end of the feeding trial.  
2.3 Sampling 
 
Bt -maize feeding trial  
After 45 days of feeding (75 days post hatch), ten fish were sampled from each tank and 
weight and length determined. The intestine was carefully dissected out from six fish per tank 
and preserved in liquefied nitrogen and stored until analyzed (-80 ºC). Blood was collected 
from four fish.  
 
DON feeding trial 
After 45 days of feeding (75 days post hatch), seven fish were sampled from each tank and 
weight and length determined. The intestine was carefully dissected out from four fish per 
tank and preserved in liquefied nitrogen and stored until analyzed (-80 ºC). Blood was 
collected from three fish.  
For both trials, the sampling was performed one tank at the time; therefore, to obtain the same 
feed status (14 hours post feeding), fish were fed at different hours according to a sampling 
schedule the last day of the trial. Prior to handling the fish were euthanized by immersion in a 
mixture of ice and water as described by Wilson et al. (2009). Each fish were weighed to the 
nearest 0.01 g, measured to the closest mm and sex was determined. The collected fish were 
randomly distributed to either dissection (intestine) or blood sampling. During dissection the 
intestine was separated from the connective tissue and the mid intestine was frozen in liquid 
nitrogen. The blood was collected by tail cutting. The tail was cut posterior to the anal fin and 
blood was collected into a heparinized capillary tube held towards the exposed caudal vessels. 
An approximately equal amount of the collected blood was carefully placed on the end of a 
glass slide to produce blood smears.  
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Another glass slide was placed in front of the drop and pulled towards the drop at a 45 ° angle 
to smear the blood droplet. When the second glass slide hits the drop it spreads and the glass 
slide is pushed gently forward to create a thin layer of cells. An illustration of the procedure is 
showed in the figure 2.3. The glass slides were left to air dry before they were fixed in 
methanol and stained.  
 
Figure 2.3:  How to create a blood smear. (Cytopath, 2009) 
 
 
2.3.1 Staining procedure  
May-grünwald (Merck KGaA, Darmstadt, Germany) and Giemsa (Merck KGaA, Darmstadt, 
Germany) staining solutions were used to stain the blood smears. After being fixed in 
methanol, the glass slides were immersed into equal parts of May-grünwal color solution and 
Sørensens phosphate buffer solution (pH 6.8) for 5 minutes. The slides were directly 
transferred to a 1:10 mixture of Giemsa color solution and Sørensens phosphate buffer 
solution for 15 minutes. To rinse of the excess color the slides were washed several times by 
immersion in Sørensesns phosphate buffer solution before air dried and stored.  
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2.3.2 White blood cell count 
The lymphocytes were characterized by the nucleus that fills most part of the cell, whilst the 
monocytes have a kidney shaped nucleus and therefore more visual cytoplasm. The 
granulocytes are characterized by the split or granulated nucleus (Lieschke et al., 2001). 100 
white blood cells were counted for each blood smear. The cells were differentiated into 
lymphocytes, monocytes and granulocytes. The cells were differentiated at 40 X (Olympus 
BX51), and pictures were taken from each slide (Nikon DS Fi1). Figure 2.3 gives an illustration 
of the different leucocytes.  
 
Figure 2.3: The picture shows the three different types of leucocytes that were differentiated between 
(Walgreens, 2011).   
 
2.4 Cry 1Ab examination and Quantitative Real-Time reverse 
transcriptase PCR 
 
2.4.1 Cry 1AB protein analysis 
Principle 
The test for cry1Ab protein is a direct Double Antibody Sandwich (DAS) ELISA. Antibodies 
specific to cry1Ab have been coated to the test wells of a micro plate. If cry1Ab protein or 
cry1Ac protein is present in the sample, it will bind to the antibodies and be captured on the 
micro plate. An enzyme conjugate is added to detect any captured protein. After a short 
incubation the micro plate is washed to remove any unbound enzyme conjugate and sample. 
TMB substrate is added to the micro plate. If the conjugate is present a color will be produced 
signifying the presence of cry1Ab or cry1Ac.  
 
Procedure  
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The test samples consisted of the GMO-maize and the non GMO maize, the GMO feed and 
the non GMO feed.  
In addition was there a fifth sample of extruded salmon feed that had been used for a previous 
feeding trial with GM maize, to investigate if the extrusion of feed affects the presence of cry-
protein. The salmon feed sample was included to investigate breakdown of cry-protein during 
normal feed processes. All other components of the test were found in the Bt -cry1Ab/1Ac 
ELISA Kit (agdia©). An equal amount of the samples was weighted and mixed with 1 X 
PBST buffer at a ratio of 1:10 (tissue weight in g : buffer volume in ml). The enzyme 
conjugate was diluted with the RUB6 enzyme before 100 µl was dispensed into each test well. 
A color grid was created based on the provided control sample that was double diluted for 
each grid decrease. The test samples were added to the wells with four parallels for each 
sample. After incubation for 2 hours at room temperature the plate was emptied and 
thoroughly rinsed with the 1 X PBST buffer. When all excess liquid had been removed the 
TMB substrate was added to the test wells and the plate was incubated for 20 minutes. The 
results were evaluated both visually and measured with a plate reader at 650 nm.  
 
2.4.2 RNA extraction by Qiazol  
Principle 
RNA is extracted using the principles first described by Chomczynski and Sacchi (1987). 
Their method is based on the chemical Trizol, whilst the extraction process for this study uses 
Qiazol which is a chemical equivalent to the original procedure except lower in cost. 
 Qiazol denatures the proteins and ruptures the cell walls allowing the nucleus protein to 
separate from the nucleic acid (Chomczynski and Sacchi, 2006). The tissue sample is 
homogenized in Qiazol. Chloroform is added to separate RNA from DNA which splits into a 
pink organic phase and a clear aqueous phase where the clear supernatant phase holds the 
RNA. The addition of isopropanol precipitates the total RNA.  
 
Procedure  
All areas and equipment used during RNA purification were treated with RNAse Zap to 
remove any RNAse that can contribute to degradation of the RNA. The whole tissue sample 
was transferred quickly to precellys tubes containing 1 ml of qiazol lysis reagent (QIAGEN, 
Norway) with 3 zirconium beads and homogenized at 600 rpm in 3 x 15 seconds with 10 
seconds interval (Precellys 24 lysis & homogenization instrument, Bertin Technologies).  
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After homogenization, 200µl of chloroform was added, the tubes firmly shaken and incubated 
for 3 minutes at room temperature before centrifuged at 12000 g for 15 minutes at 4°C 
(Eppendorf Centrifuge 5415 R). The supernatant was transferred to 1. 5 ml RNase free tubes 
containing 500 µl of isopropyl alcohol and stored at 4°C for 1 hour.  
Centrifuging the tubes at 12 00 g for 30 minutes at 4 °C gave small RNA pellets at the bottom 
of the tubes. The pellet was washed by removing the supernatant using a suction pipette (IBS 
Integra Biosciences, Vacuboy, Switzerland) and shaken with 1ml of ice cold 75 % EtOH with 
diethyl pyrohydrocarbonate, DEPC, treated water.  The tubes were vortexed before 
centrifuged at 10 000 g for 5 minutes at 4°C. Again the supernatant was discarded. The RNA 
pellet was left to dry completely before it was dissolved in 30µl double distillated water 
(MilliQ biocel) and stored at -80 ° C.  
 
2.4.3 RNA quantification and purity 
Principle 
The amount of RNA is measured using a spectrophotometer (Nanodrop ND 1000, Thermo 
Scientific). The nanodrop also gives an indication of purity of the samples. At 260 nm, RNA 
has it highest absorption and it is the most correct wavelength to indicate RNA concentration 
in the sample (Imbeaud et al., 2005). The ratio of the absorbance at 260 and 280 (A260 /A280) 
indicates purity of the sample. However, the A260 measurement might be compromised by 
the presence of genomic DNA leading to over-estimation of the actual RNA concentration.  
The A280 measurement will give an estimate of the presence of protein but provides no 
information on possible residual organic contaminants which is considered at 230 nm. Pure 
RNA will have A260/A230 equal to A260/A280 and greater than 1.8 (Imbeaud et al., 2005).  
 
Procedure 
1.5 µm of a sample was loaded onto the measurement pedestal of the Nanodrop 
spectrophotometer (ND 1000, Thermo Fish Scientific). Surface tension between the lower and 
upper pedestal held the sample in place during the measurement. The RNA concentration and 
ratios were directly presented on the connected computer screen.  
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2.4.4 Second precipitation  
Principle 
The samples that had low quality when measured on the nanodrop were precipitated a second 
time to improve purity. For the final results to be reliable the quality of the samples should be 
approximately equal.  
 
Procedure  
The samples were added 70 µl of double distillated water (ddH2O), 250 µl of absolute ethanol 
and 10 µl of a 3M sodium acetate solution and stored in - 80°C over night. The next day the 
samples were centrifuged at 12 000 g for 30 minutes at 4°C resulting in formation of a new 
RNA pellet at the bottom of the tube. The supernantant was removed and the pellet was 
washed with 75 % EtOH with DEPC treated water, vortexed thoroughly and centrifuged at 
10 000 g for 5 minutes at 4°C.  After centrifugation the supernatant was removed, and after 
the pellet was dried completely was it dissolved in 30 µl ddH2O.  
 
2.4.5 DNAse treatment 
To ensure that there were no DNA left in the samples they were treated with a DNA-free kit 
(Ambion® DNA free
TM,
 Invitrogen).  Reagents for the entire procedure were found in the kit. 
Each sample was added 3µl DNase I buffer and 2µl DNase I enzyme and incubated at 37°C 
for 30 minutes. After incubation the samples were added 5 µl of the “slurry” part of the 
DNase inactivation reagent vortexed and incubated for 1 minute at room temperature before 
centrifuged at 10 000 g for 1 minute. The grey matter of the inactivation reagent created a 
mass at the bottom of the tube, leaving a clear supernatant to be transferred to a new 1.5 ml 
RNase free tube.  
 
2.4.6 RNA quality on bioanalyzer  
Principle 
The bioanalyzer provides electrophoresis separation of small amounts of RNA when high 
voltage is lead to samples in solution. The separation is based on molecular weight and is 
detected via fluorescence. The amount of detected fluorescence correlates with RNA of a 
certain size and is visualized as an electropherogram  (AgilenTechnologies, 2008).  
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An RNA Integrity Number (RIN) is given to each sample, which is a measure of degradation 
of the RNA based on the graphs and thus ruling out manual interpretation. The values range 
from 1 to 10, where RIN 1 indicates totally degraded RNA and RIN 10 signifies intact RNA.  
 
Procedure 
The quality of the RNA was measured using BioaAnalyser (RNA 600 Nano, Agilent 
Technologies, Germany) and the samples were prepared with a chip priming station (Agilent 
Technologies) and the 600 nano labchip kitt (Agilent Technologies).  
0.5 µl of dye concentrate was added to a small tube containing 32.5 µl filtered gel.  
The mix was thoroughly vortexed and centrifuged at 13 000 g for 10 minutes (Eppendorf 
centrifuge 5415 R) at room temperature. Samples with RNA concentration above 500 ng/µl 
was diluted with ddH2O and all samples were denatured at 70 °C for 2 min before analyzing. 
The 600 Nano Chip was added the gel-dye mix, a nano marker and 5µl of each sample. 
Before it was run in the bioanalyzer was the chip votexed for at 2400 rpm for 1 minute in the 
IKA vortexer (IKA
®
Werke GmbH & Co. KG). An example of the result presented by the 
bioanalyzer is found in appendix III figure A.  
 
2.4.7 Preparation of cDNA  
Principle 
In advance of quantitative real time polymerase chain reaction (qPCR) RNA is transcribed 
into complementary DNA (cDNA) by the enzyme reverse transcriptase.  
 
Procedure 
The cDNA tray (96 AB gene PCR plate, Thermo Scientific) consisted of standard solutions 
and the RNA samples, all in triplets. In order to prepare the standard solution, a “pool” of all 
the samples was made. The “pool” consists of 500 ng RNAfrom all the samples. The 
standards, 100 ng/µl, 50 ng/µl, 25 ng/µl, 12.5 ng/µl, 6.25 ng/µl and 3.125 ng/µl (± 5%) were 
prepared using the sample “pool” and ddH2O water. All the RNA samples were diluted to a 
concentration of 25 ng/µl ± 5%.  A real time reactions mix was added to the wells prior to the 
standards and the samples. The specific amount of the reagents for the reaction mix is listed in 
appendix IV B. 20µl of the reaction mix and 10 µl of a sample were added to each of the 96 
wells in addition to two negative controls; non application control (nac) consisting of the 
reaction mix without the multiscribe enzyme and a non-template control (ntc) without RNA.  
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The Real Time plate was covered by an RNase free rubber mat before centrifuged at 50 x g 
for 1 minute (Eppendofr centrifuge 5810 R).  The transcription took place in a PCR machine 
(Gene Amp PCR System 9700 PCR machine, Applied Biosystems) during a specific thermal 
cycling program. The specifications are showed in appendix IV C. 
 When the program was finished the RT plate was diluted with 30µl of ddH2O, covered with a 
plastic film and stored at -20°C.  
 
2.4.8 Preparation and testing of primers 
Principles 
The primes from Invitogen in table 2.1 were tested before they could be used for qPCR. The 
test is performed with reverse transcriptase (RT) and polymerase chain reaction (PCR) 
prepared in one tube. Thereafter the products are run in an agar gel to verify that the primer 
pair creates strong bonds.   
 
Procedure 
The primes were diluted with TE buffer based on the concentration of each primer. A master 
mix containing a RNA template, dNTP, RT-PCR enzyme mix and buffer (QIAGEN) was 
prepared. The amounts are presented in appendix V A. The reaction mix was added a forward 
and reveres primer. The tubes were subjected to a thermal cycle in the PCR machine (Gene 
Amp PCR System 9700 PCR machine, Applied Biosystems). The specific times and 
temperatures are showed in appendix V B.  
The products were stored in 4°C over night. An agar gel was prepared with agar power and 1 
x TAE heated in a conventional microwave owen. The products from the RT-PCR reaction 
were mixed with a loading buffer in a 1 to 6 ratio. Running buffer (1 x TEA) covered the 
whole gel. A DNA ladder/marker was loaded in the well next to the sample. After connecting 
the wires the voltage was set and the gel was run before it was photographed in gel doc.  
 
2.4.9 Quantitative real time polymerase chain reaction 
Principle 
The quantitative Real Time polymerase chain reaction is based on the principles behind the 
PCR method which was developed by Kary Mullis during the 1980s. Basically, PCR  can 
amplify small specific cDNA sequences and produce high numbers of identical sequences in a 
short time to be used for further analyses (Kubista et al., 2006).  
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The invention of Real Time PCR made it possible to monitor the amplification process (Nolan 
et al., 2006). There are basically three steps for gene quantification.  
The first is the previous described reverse transcriptase reaction which turns DNA into cDNA, 
which is amplified through PCR and then detected using quantitative Real Time PCR. For 
each cycle during the PCR reaction the number of cDNA is doubled.  
There is a need for two oligonucleotide primers which have the complimentary sequence to 
the DNA template to amplify the specific DNA strains. The reaction also requires the heat-
stable DNA polymerase enzyme, the four nucleotide triphosphates (dNTPs) and magnesium 
ions in the buffer (Kubista et al., 2006).  During each cycle the temperature is increased to 
separate the double stranded DNA (dsDNA), lowered to anneal the primers to the template, 
and increased again to optimize the temperature for the process where the dNTPs extends the 
primers as illustrated in figure 2. 4.  
 
                              
 
Figure 2.4:  The PCR temperature cycle. Initially  the temperature is raised to  melt the dsDNA, and then 
lowered to let primers anneal and conclusively raised to let the polymerase extend the primers (Kubista et al., 
2006). 
To be able to detect the amount of DNA produced a fluorescent probe is added to the primer 
mix. The probe binds to the DNA products and gives for a fluorescent signal that correlates to 
the amount of DNA produced.  
 Figure 2.5 shows the different phases of the PCR reaction. During the first cycles the signal is 
low, then when the amount increases the signal increases exponentially until it reaches a 
plateau where is saturates due to limitations of the reagents (Kubista et al., 2006). It is not the 
saturation level that provides information on the amount of DNA present; it’s the response 
curve that shows the difference in the initial amount of DNA. 
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 The quantification is achieved by comparing the number of heat cycles needed to reach a set 
signal level referred to as the CT value as illustrated in figure 2.5. 
 
Figure 2.5: The phases of PCR on the left side (VanGuilder et al., 2008) and  Cycle curves and CT values on the 
right side (Kubista et al., 2006).                                                     
 
The CT value is inversely proportional to the amount of a specific DNA sequence in the 
original sample, and can therefore be used to determine the relative quantity of the expressed 
gene. Housekeeping genes are used as an internal reference to the gene in question (Jain et al., 
2006). The CT values of the housekeeping gene are used to normalize the differences among 
the different DNA sequences by compensating for biological differences. There are no 
universal housekeeping genes, usually genes which are expressed constant in the tissue for the 
sample in question is chosen (Kubista et al., 2006).  
Procedure 
The RT-plate with the previously prepared cDNA was centrifuged at 100 x g for 1 minute and 
vortexed at 1100 x g for 3 minutes before use.  
The reaction mix consisted of forward and reverse primer pairs, SYBR GREEN master 
reagent and ddH2O. The list of primers is presented below in table 2.1, and the reaction 
reagents are listed in appendix VI B.  
8µl of the reaction mix and 2 µl of the template cDNA were transferred to a 384-well real-
time PCR plate by a robot (Biomeck 3000 Laboratory Automation Workstation, Beckman 
Coulter).The qPCR reaction consisted of 45 cycles and was carried out by a LightCycler 480 
(Roche). The belonging software presents amplification curves and CT values.  
The calculated efficiency and error for the standard curves was acceptable at respectively 1.8-
2.2 and below 0.04.  
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2.5 Equations and statistical analysis  
 
The condition factor and specific growth rate for the fish were calculated to measure fish 
performance using the equations presented below.  
 
 
 
 
 
The real time quantitative PCR gene expression data from the mid intestine were normalized 
using the normalization factor acquired from geNorm algorithm.  
The statistical analysis was performed using the graph pad prism (Version 5.04, Graph Pad 
software ®). One of the main criteria for analysis was that the data were obtained from a 
population that follows Gaussian distribution. The normalized data were therefore tested for 
normality using the d'agostino and pearson test from the graph pad prism 5 software.  
Student’s t-test was used on the data from the Bt-maize trial to determine if there were any 
significant differences between the parameters related to growth performance (weight, length, 
condition factor or specific growth rate), mean normalized expressions (MNE) of the mid-
intestine and differential count of white blood cells.    
One way analysis of variance (ANOVA) was used  on the data obtained from the DON dose 
respons trial to identify if there were any difference between the parameters related to growth 
performance (weight, length, condition factor and specific growth rate) , MNE of the mid-
intestine and differential count of the with blood cells. The same parameters were tested for 
linear regression to analyze for dose responses.  
A significant cut of value was set at p ≤ 0.05 for all statistical analysis. Significant differences 
for the ANOVA omnibus were further explored using Tukey's Honestly Significant 
Difference (HSD) test. 
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Table 2.1: The genes selected to evaluate mid-intestinal gene expression presented with forward and reverse primers and the RefSeq accession numbers for the 
sequences from which the primers were designed. 
Gene Forward  Reverse  Accession nr 
Cyclin G1 
 
GACTCCGCGTCATCGAGTCCG AACGTCTCCGCACAGAAGCCAA NM_199481 
Proliferating cell nuclear 
antigen 
TCGGGTGAGTTTGCCCGCATC GCCCAGCTCTCCGCTAGCAGA NM_131404 
Caspase 6 AGGACAGCGCTTCAGCAGGACA 
 
TGAGAGCCATTCCCCGTCTCTTGT NM_001020497 
 
Interleukin 6 receptor TCAGCCAGAGGAGCAGGATGCC TGTGTGACCCACTGCGGGGTT NM_001114318 
Sodium glucose co-
transporter 
GGACGCACTTGCCCTCCTCA TCCCACCGCCAGAACCACCA NM_200681 
Maltase-glucoamylase TGAGGGGAGAGGGCATGCGT GCTGAGCGCAGGAGGCCATTT XM_001919100 
Cytochrome P450, family 1, 
subfamily A , Cyp1A 
TCCACTCGATCGCTCCGGGTT GCGGTTTAGGCGCATGAGCAGAT NM_131879 
Ghrelin/obestatin 
preprohormone 
GTGCCGTGCCAGCAGCATGT TGGCCTTCGACCCTGCGGTT NM_001083872 
Mitogen-activated protein 
kinase 14a, Mapk14 
AGCTACTGCGGGGGACTCGT CTTTCCCTGCTCGTCCGCCC NM_131722 
 
CuZn SOD CGCATGTTCCCAGACATCTA GAGCGGAAGATTGAGGATTG Y12236 
Eukaryotic translation 
elongation factor 1 alpha 1 
AGACAACCCCAAGGCTCTCA CTCATGTCACGCACAGCAAA NM_001017795 
B-actin CGAGCAGGAGATGGGAAACC CAACGGAAACGCTCATTGC  
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3 Results 
3.1 Feed ingredients and diets 
 
The genetically modified (GM) maize had a DON concentration of 769 µg/kg, which is nearly 
twenty times higher than the non genetically modified (non GM) maize. However, the non-
GM maize had minimal levels of the fumonisins and aflatoxins. Only trichothecene 
mycotoxins were analyzed in the feed, and the only toxin above the detection limit for the two 
diets was DON in the GM maize feed, with a value of 80 µg /kg feed.  
Only the added synthetic DON was detected during analysis of the feed for the DON feeding 
trial, with values increasing from less than 20 up to 3000 µg DON 
-1
 kg feed. 
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Row 1 
Row 2 
Row 3 
3.2 ELISA Cry protein test 
 
In the first row of the ELISA plate, row 1, well 3-13 shows the color changes caused by the 
standard sample with an established content of cry protein (cry1Ab). The first four wells in 
the second row, row 2, is test material from the non-GM maize whereas well 4-8 in row 2 
consist of samples from the GM maize. Wells 9-12 in row 2 consist of test material from the 
non-GM feed, whilst the four first wells of row 3 contain test material from the GM feed. The 
final 8 wells in row 3 is the additional test material, the GM and non-GM salmon feed which 
has been heated during normal production processes like feed extrusion.  
 
Figure 3.1: An ELISA test plate with standard samples compared with the feed maize material and from the non-
GM and GM feed. The blue color in the test wells with GM maize and GM feed shows the presence of cry 
protein.  
 
The color changes clearly illustrate the difference between the GM and non-GM ingredients 
and feed. There is a presence of the cry1Ab protein in the GM feed when comparing the 
change in color with the certified test material. The results for the heath treated salmon feed 
with GM maize confirms that the cry1Ab protein is not heat stable and destroyed during 
normal salmon feed processing.   
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3.3 Growth performance 
 
Bt -maize feeding trial 
Feed acceptance was high over all and no differences were seen in feeding behavior amongst 
the different diets. The final weights of the two different feeding groups were 200 and 187 mg 
for the GM group and non-GM respectively. The results are presented by the graphs in figure 
3.2. There was no significant difference (p= 0.30) between the group fed GM maize and non-
GM maize.                                                                 
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Figure 3.2: The graph shows the final average weight (75 days post hatching) for the fish within the two different 
feeding groups. Each Colum represents the average value for each group shown with maximum and minimum 
values ± SEM.  
Table 3.4 shows the average final weight, length, condition factor and specific growth rate 
after 45 days. There were no significant differences in any parameters between the fish fed 
GM feed and non-GM feed. 
Table 3.1: Growth performance for the two different diets given as mean (n=3) ±SD 
Feed 
Weigth 
(mg) 
Length 
(mm) Condition factor Spesific growth rate 
GM 200 ± 54 26 ± 2 1.0 ± 0.1 4.5 ± 0.4 
non-GM 186 ± 55 26 ± 3 0.8 ± 0.1 3.7 ± 0.5 
T-test ns ns ns ns 
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DON feeding trial  
The feed acceptance was good for all the groups and all of the feed was consumed rapidly. 
We observed that the group fed the 3.0 ppm concentration consumed the feed somewhat faster 
and seemed hungrier compared to the other tanks. However this did not results in any 
significant difference in the final weight of the group (p=0.6).  Mortality during the trial was 
negligible. Figure 3.3 shows the average final weight of the fish in each group at the end of 
the trial. 
 
 
 
 
 
 
 
 
Figure 3.3: The graph shows the final average weight (75 days post hatching) for the fish in each group. Each bar 
represents the minimum and maximum values ± SEM for the groups.  
Condition factor and specific growth rate was also calculated to evaluate performance for 
each of the groups. There were no significant differences between the evaluated performance 
parameters. The values for each diet are presented in table 3.5. 
Table 3.2: Performance parameters for the different diets. Results are presented as mean ± SD  
DON 
concentration 
(ppm) 
    Weight  
(g) 
      Length  
(mm) Condition factor 
Specific growth 
rate ANOVA 
0 218 ± 84 26.9 ± 4 1.1 ± 0.2 4.8 ± 0.2 ns 
0.1 235 ± 86 27.2 ± 3 1.2 ± 0.2 5.0 ± 0.3 ns 
0.5 197 ± 59 26.6 ± 2 1.0 ± 0.1 4.6 ± 0.3 ns 
1.5 204 ± 70 26.5 ± 3 1.1 ± 0.2 4.7 ± 0.3 ns 
2 216 ± 68 26.9 ± 3 1.1 ± 0.1 4.8 ± 0.4 ns 
3 177 ± 76 26.7 ± 3 0.9 ± 0.1 4.8 ± 0.4 ns 
       
Weight DON
ppm DON
g
0.0 0.1 0.5 1.5 2 3
0
100
200
300
400
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3.4 Mid intestine gene expression 
 
Bt -maize feeding trial 
A set of transcripts encoding proteins involved in oxidative stress (CuZn sod, mapk 14, 
cyp1A), the cell cycle (caspase 6, cyclin G1, PCNA), the immune system (interleukin 6), 
appetite regulation (ghrelin) and intestinal function (maltase glucoamlyse, sodium glucose co-
transporter) were quantified in the mid intestinal tissue.  Mean normalized expression (MNE) 
for the investigated gene transcripts were between 0.5-1.3.  Figure 3.4 show all of these 
transcripts presented as mean normalized gene expressions (MNE) ± standard error of the 
mean (SEM). Dietary cry1Ab and natural DON exposure did not affect any of these. The 
transcript encoding protein for mapk 14 and ghrelin were the only one showing a trend 
towards significant difference, with p=0.06 and p= 0.16 respectively, where the group feed 
GM maize were highest for both. The transcripts for interleukin 6, ghrelin and cyp1A are also 
slightly higher for the GM maize group. For the remaining genes, caspase 6, maltase-
glucoamylase, sodium glucose co-transporter, cyclin and PCNA, the transcript results are 
nearly equal.  
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Figure 3.4:  The MNE data for each gene transcript for the Bt -maize trial. The graphs are given as mean (n=3) ± SEM
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DON feeding trial 
A set of transcripts encoding proteins involved in oxidative stress (CuZnSOD, mapk 14, 
cyp1A), the cell cycle (caspase 6), the immune system (interleukin 6), appetite regulation 
(ghrelin) and intestinal function (maltase glucoamlyse, sodium glucose co-transporter) were 
quantified in the mid intestinal tissue. Mean normalized expression (MNE) for the 
investigated gene transcripts were between 0.5-1.5 for all genes.  Figure 3.5 shows all of these 
transcripts presented as mean normalized gene expressions (MNE) ± standard error around 
the mean (SEM). There were no significant differences between the dietary groups, and there 
were no dose response to the increase in DON concentration. The dietary groups with low 
DON concentrations (0.0, 0.1, 0.5) have a trend towards slightly higher transcripts for both 
caspase 6, sodium glucose co-transporter, Mapk 14, CuZnSOD and cyp1A. Interleukin 6, 
ghrelin and maltase-glucoamylase all have scattered variations for all the groups.  
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Figure 3.5: Average MNE for the gene transcript evaluating mid-intestinal health for increasing DON contamination (n=5) ± SEM
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3.5 Differential counts of white blood cells 
 
There were big differences within each group for the differential count of the white blood 
cells and there was no significant difference between the dietary groups for either of the trials.  
The picture below illustrates the different types of cells that were categorized. The 
lymphocytes dominated with an occurrence of around 90 % on average.  
Figure 3.2: Pictures of the different blood cells (X40) that were differentiated during blood cell count.  
 
Table 3.6: The average values of the different white blood cells for both trials. The average values are 
based on individual fish for each of the dietary groups.  
 
DON cocentration (ppm) Maize diets 
Leucocytes 0.0 0.1 0.5 1.5 2 3 Non-GM GM 
Lymphocytes 90 ± 5 87 ± 7 93 ± 3 91 ± 5 91 ± 6 88 ± 5 81 ± 14 89 ± 4 
Monocytes 7 ± 4 11 ± 8 7 ± 3 8 ± 5 9 ± 6 8 ± 4 13 ± 10 9 ± 3 
Granulocytes 3 ± 3 3 ± 8 0 ± 0 2 ± 5 1 ± 1 4 ± 3 5 ± 4 3 ± 1 
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4 Discussion  
 
4.1 Methodological considerations  
 
4.1.1 Feeding and design 
Although each tank was given an equal amount of feed, there is no guaranty that the feed was 
distributed evenly amongst the fish. The fish were always hungry after feeding and perhaps 
less restricted feeding could have given alterations in our results. Hierarchy behavior in the 
tank, due to a restricted diet, could explain some of the difference within the groups 
The experimental design for the DON feeding trial is strong as it has 4 and 5 replicates for 
each of the DON concentrations, however, there were only 3 replicates for the Bt –maize 
feeding trial. Additional tanks could have enhanced the trend towards difference observed in 
growth and mapk14.   
Also, to improve the relevance of the Bt -maize feeding trial, additional diets should have 
been included so that the data could be compared to standard feed also.  
4.1.2 Gene expression analysis 
The isolation of RNA by the principles of acid guanidinium thiocyanate-phenol-chloroform 
extraction and gene expression quantification by quantitative Real-Time reverse transcription 
polymerase chain reaction are well established methods both in the scientific community 
(Chomczynski and Sacchi, 2006, Bustin, 2000), and at the molecular lab at NIFES where the 
samples were prepared. In addition are there several measurements during the sample 
preparation stages to ensure that the quality of the samples is satisfactory to ensure reliable 
results. The intestinal samples that were below 1.8 for the 260/230 ratio measured by the 
nanodropp, or below 7 for the RIN number after isolation of the RNA were eliminated from 
the trial. There are several elements to be aware of in the process leading up to QRT PCR, 
where a number of the problems that can occur are most likely to originate from the RNA 
isolation step (Bustin and Nolan, 2004). It is generally recommended in scientific literature to 
extensively test the RNA integrity for each sample, however, the routine at the lab only test a 
random selection of the isolated samples anticipating that if the quality of those are good, so 
are the rest of the samples that have been treated in the same way.  
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If some of the samples were degraded it could cause false differences when measured by the 
QRT PCR. The RNA integrity, defined by the RIN number, was excellent (above eight) for 
all the randomly collected samples that were tested for our trial indicating that there is a 
homogenous quality amongst the samples.   
There were no known obstacles during the laboratory procedures that should reflect on the 
outcome of the results.  
4.1.3 White blood cell differentiation 
The blood smears were of very different quality as collecting blood from the zebrafish was 
not an easy task. The blood collected from the tail will most likely contain other body fluids 
as well, and possibly water from the outside of the fish. Because of this, the blood was not as 
viscous as it should be and it was difficult to perform the smears. The smears that were of low 
quality were not counted to obtain a reliable result. Other ways of collecting blood like heart 
puncture could have been explored before deciding on method.  
 
4.2 Feed ingredients and diets 
 
The level of deoxynivalenol (DON) in cereals found in the survey by the Norwegian food 
safety authority had an average DON contamination around 0.2-0.3 ppm (Clasen and Børsum, 
2012).  This level is lower than the naturally contaminated GM maize ingredient used for our 
study which was 0.7 ppm. An inclusion level of 19 % was used for our maize diets resulting 
in a DON concentration in the GM maize diet of around 0.1 ppm. This is  much lower than 
the guidance value given for DON in complementary and complete feeding stuffs which is 5 
ppm (EU, 2006). DON contamination of wheat, barley and maize has had an increasing focus 
in the later years, and there has been reports of growing problems which are suggested to be 
due to climate changes (McMullen et al., 1997). However, there is a lack of knowledge 
regarding the effects of DON and mycotoxins in general in aquaculture species. Adverse 
effects on performance and health has been found in Atlantic salmon fed DON levels below 
this guidance value (Döll et al., 2010). In addition to the presence of DON, the GM maize diet 
also contained the transgenic protein, cry1Ab. Exactly how much cry1Ab is expressed by the 
GM maize is dependent of the event, growth stage and tissue.  
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Few scientific investigations have been performed with focus on the stability of the amount of 
cry1Ab expressed from event MON810 which was used for our trial (Nguyen and Jehle, 
2007). The producer of the event, Monsanto, has reported of stable values of cry1Ab from this 
event, however the average numbers reported from the producer deviates from the 
investigations made by Nguyen and Jehle (2007). Our maize was only qualitative tested to 
verify the presence of the toxin and did not determine the amount. For further discussion, I 
will assume that the  average amount of cry protein produced in the whole plant from event 
MON 810 be 4 ppm wet weight, based on the results from Nguyen and Jehle (2007). This 
gives, with an inclusion level of 19 %, approximately 0.8 ppm feed. In a salmon study by 
Sanden et al. (2005)  was the amount of cry1Ab in the  maize ingredient measured to 0.11 to 
0.13 ppm which is much lower than reported by both Monsanto and Nguyen and Jehle (2007).  
Sanden et al. (2005) concluded that the cry1Ab level in the feed, with an induction level of 12 
%, did not affect the fish considerably. One of the reasons why few studies provide 
information on the amount of cry1Ab in the maize used for the trial might be because there 
are usually no distinctive observed effects. However, a recent study with human cells showed 
that a concentration of 100 ppm cry1Ab caused cell death,  although much higher than what 
generally occurs, disagreeing that cry1Ab is totally harmless for other species that the 
European corn borer (Mesnage et al., 2012). 
The increased level of DON that was found in our GM maize ingredient has also been 
reported in other studies (Sissener et al., 2011a). It was discussed by Sissener et al. (2011a) 
that the DON contamination could be a confounding factor in trials investigating effects of Bt 
-maize. However, higher levels of DON in Bt -maize  is contradictory to several studies where 
Bt -maize expressing cry1Ab protein has resulted in lower mycotoxin concentration compared 
to the near-isogenic traditional maize (Bakan et al., 2002, Ostry et al., 2010). Zeralenone and 
fumonisin are clearly reduced in Bt -crops, while the relationship towards DON is not so 
distinctive (Ostry et al., 2010).  Magg et al. (2002) investigated several locations over two 
years and found that even though Bt -maize significantly reduced the amount of damage on 
the maize crops overall, it did not consistently reduce the concentration of DON over all 
locations and years.  The conflicting results indicate that the effects of the Bt -maize show a 
discrepancy between locations. This might be correlated to the proven variation in amount of 
cry1Ab expressed within the same event. Also, since the effect of the GM maize is usually 
compared to its near-isogenic parental line, the qualities of this might also influence the effect 
Bt -maize displays.  
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To be able to differentiate between primary effects (cry1Ab) and secondary effects (DON) in 
fish fed the GM maize diet, a regression design with increasing levels of DON was run in 
parallel with the maize trial. The diets in this study were spiked with increasing level of DON 
to specifically cover the levels of DON that was found in the contaminated GM maize and 
also what would naturally occur in contaminated maize (Griessler et al., 2010). The diets for 
the two trials were the same except for the starch source which was dextrin for the DON diets 
to eliminate further mycotoxin contaminations. The level of DON was also analyzed in the 
non-GM maize ingredient and was only 0.04 mg/kg. It was also found low levels of aflatoxin 
(0.02 mg/kg) and fumonisin (B1, B2, B3 0.15 mg/kg), these levels were however considered 
too low to have any effects in the fish at an inclusion level of 19 % maize.  
 
4.3 Growth performance 
 
All tanks in this study were given an equal amount of feed twice every day and all feed was 
rapidly ingested, indicating very good feed acceptance. The zebrafish given GM maize did not 
show any difference in feed acceptance when visually compared to the fish feed traditional 
maize. The same was observed in the DON trial except for the 3 ppm group which seemed 
hungrier. However, at the end of the trial there were no significant differences in growth, 
length, SGR or CF between any of the groups for either of the trials. Even though not 
significant, the average growth of the fish feed GM maize was slightly higher compared to the 
non GM group. This is consistent with findings by Sissener et al. (2010) where zebrafish fed 
GM  maize had a higher weight. Increased growth was also found in a feeding trial with pigs 
using the same batch of maize as used in our study (Walsh et al., 2012). Results from the Bt -
maize feeding trial indicate that the cry1Ab expressed by Bt -maize have little or no effect on 
feed intake and growth of the fish. And if cry1Ab has an effect, it mighth be speculated that it 
actually enhances growth. Otherwise else, perhaps the low DON levels could be enhancing 
the growth. In the DON trial, fish fed 0.1 ppm DON, the same concentration of DON as in the 
GM maize diet, had the highest average growth, although not significant. Even though DON 
has been shown to be imunostimulatory, it has not been found to increase growth (Pestka et 
al., 2004). When Atlantic salmon (Salmo salar) was given GM maize contaminated with 
DON the opposite was observed (Hemre et al., 2007).  
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The conflicting results indicate that different aquatic animals might have different responses 
to the Bt -maize regardless if the effects are caused by the cry1Ab protein or confounding 
factors. When comparing our growth data with the reference growth curve for zebrafish 
established by Gomez-Requeni et al. (2010), our fish had a lower weight that expected form 
their results. However, there are several components that differ between the conditions for our 
zebrafish. Their fish were fed ad libitum on formulated feed and Artemia naulii and were kept 
in bigger tanks with lower fish density that for our trial. These differences provide one 
explanation why the growth for our trial deviate from the growth in the Gomez-Requeni et al. 
(2010) trial. 
4.4 Mid intestine – gene expression analysis 
 
A total of eight genes were investigated for both feeding trials, which were selected based on 
reported effects of DON in other animals and results from previous studies with GM maize. 
Our results indicate that the zebrafish mid intestine is not very sensitive to low levels of 
cry1Ab in combination with natural DON or synthetic DON as none of the investigated gene 
transcripts were significantly different between the feeding groups. 
Mitogen-activated protein kinases (mapks) are reported to be markers of ribotoxic stress and 
important transducers of downstream signaling events related to immune response and 
apoptosis (Pestka et al., 2004).  Ribotoxic stress is a mechanism which has been linked to the 
presence of DON where DON can, by binding to the ribosomes, cause activation of the 
mitogen-activated protein kinases (Mapks). The activation of the Mapks control intracellular 
events and are related to immune responses and cell death (Pearson et al., 2001). The presence 
of DON might act differently on the same mechanism as it has been proven that low doses of 
DON can be imunostimulatory, whilst high doses cause immunosuppression (Pestka et al., 
2004). The results from both trials indicate that this might be the case of our results. The fish 
feed GM maize with low DON concentration (0.1 ppm) showed a trend towards increase gene 
transcript levels of mapk14 compared to the non-GM group. The same was observed in the 
DON trial where the low concentrations (0.0, 0.1 and 0.5) had a higher MNE of mapk14 
compared to fish feed higher DON concentrations (1.5, 2 and 3). 
 CuZnSOD, which is a cytoplasmic antioxidant involved in combating cellular oxidative 
stress (Krishnaswamy et al., 2010), was higher for the low DON doses and the Bt-maize.  
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This could indicate a protection of the cells against the toxic mechanisms of DON when only 
low doses are present.  
The hormone ghrelin, which is involved in the seronergic system, is associated with hunger 
and appetite, increases before feeding and increase during meals (Cummings, 2006). An 
increased level of ghrelin stimulates appetite and could increase both meal size and frequency. 
There was a trend towards higher ghrelin expression  in fish feed GM maize compared to the 
fish fed non-GM maize, which correlates well with the trend towards increased growth for 
this group. This may indicate that the amount of DON present in the feed is not enough to 
reduce the appetite of the fish. Keeping in mind that pigs are considered highly sensitive to 
DON contamination; reduced appetite was neither observed  for pigs at this level (Prelusky et 
al., 1994). There are variations in MNE for ghrelin between all the groups in the DON trial, 
none of which do correlate to the growth of the dietary groups.  
The level of starch is approximately the same in the GM and DON diets and similar to the 
starch level in the diets used in the salmon trial with GM maize by Hemre et al. (2007). In the 
study by Hemre et al (2007) increased maltase enzyme activity and glucose uptake was 
observed for the Atlantic salmon fed GM maize. These results were not reproduced in our 
trial as there were no significant differences between any of the diets. The differences might 
be explained by the investigated parameter, being gene transcription in our study and protein 
levels in the study by Hemre et al. (2007). Investigations on plasma glucose could be an 
additional way of investigating if there were changes in starch digestibility for the high DON 
concentrations. Furthermore, the findings by Hemre et al. (2007) are from salmon, and it is 
known that there are large differences in how a fish species digest starch in the feed 
(Krogdahl et al., 2005). Zebrafish might have a higher ability to digest starch than salmon, 
which might explain why there was now apparent difference in MNE of these two genes 
selected as markers of intestinal transport. Caspase 6 was investigated because it may be a 
sensitive biomarker both related to the primary factor (cry1Ab) and secondary factor (DON). 
DON is a known inducer of programmed cell death in relations to downstream signaling 
events of mapks (Pestka, 2008). Caspase 6 is part of a group consisting of apoptosis-related 
cysteine peptidases which are responsible for the apoptosis execution. To obtain homeostasis 
in tissues, both cell proliferation and cell death need to be controlled by regulatory genes, but 
in addition programmed cell death can be affected by outside stimuli (Soldani and Scovassi, 
2002). Caspase 6 cleaves poly (ADP-ribose) polymerase, which plays a key role in cell 
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reparation, and destroys lamins which are support structures in the cell nucleus (Soldani and 
Scovassi, 2002). There is no indication of an overexpression of caspase 6 based on our data 
suggesting that there low doses do not increase apoptosis.  
Dietary exposure to DON is known to induce rapid and temporary up regulation of pro-
inflammatory cytokine expression in mice. The latter are known to induce several suppressors 
of cytokine signaling (SOCS), some of which impair the growth hormone (GH) signaling 
resulting in reduced growth (Amuzie et al., 2009). Interleukin 6 belongs to a family involved 
in phase-response during infection and is an essential mediator for immunotoxicity (Moon 
and Pestka, 2003). Increased levels of interleukin 6 could indicate that the fish experiences 
disturbed physiological homeostasis due to toxic substances (Heinrich et al., 1998). There 
were no significant differences on gene transcript levels of interleukin 6 between fish fed any 
of the diets, although the levels for the fish fed GM feed were slightly elevated. Activation of 
interleukin 6 is connected to the Mapk mechanism, and viewing the results alongside the trend 
towards increase of mapk14 for the same group indicates that there could be a minor response 
in the fish which could be increased with higher concentrations of DON.   
The trend towards an increase of Cyp1A gene transcripts in fish fed the GM maize diet was 
not observed for the equivalent DON concentration in the DON trial. The Cyp1A function as 
a detox mechanism for DON and the trend towards an increased MNE for the fish fed the GM 
maize diet could be related to the low doses of DON, or the presence of cry1Ab protein since 
the difference was only observed in the Bt-maize trial.  
Proliferating Cell Nuclear Antigen, PCNA, is a protein used as a marker for cell proliferation 
potential. PCNA is found in eukaryotic cells and is essential for DNA replication by binding 
to polymerase-δ and D-cyclins to initiate cell cycle progression (Tiemann et al., 2003). A 
change in cell proliferation could signal further damage to the intestinal track (Sanden et al., 
2005). However no such changes were seen in the present study, which correlate well with the 
lack of difference for cyclin G1 as well, which can function as an inhibitor of cellular 
proliferation (Kimura et al., 2001).  
Since there are no significant results for the genes tested for the present study, it could be 
thought that the low doses of DON are not high enough to alter gene transcripts.  However a 
study performed on broilers chicken showed that concentrations as low as 2.5 ppm could 
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significantly alter gene expression in the liver and jejunum (Dietrich et al., 2012), In addition 
it might be supposed that the zebrafish mid-intestine is not a target organ for DON damage.  
Unpublished results on gene transcription level of liver taken from the same zebrafish as this 
study indicate that zebrafish liver is the place where the detoxifying of DON takes place 
(Sanden et al., 2012).  The study by Hooft et al. (2011) supports this theory as they found 
damages to the liver, and not the intestine in rainbow trout (Oncorhynchus mykiss) fed 2.6 
ppm DON. The fact that not all organs are effects by DON in the same way was also 
illustrated by varied effects on protein synthesis in different organs of pigs (Danicke et al., 
2006).  
4.5 Blood – white blood cell differentiation 
 
Blood has been shown to be a target for DON (Borutova et al., 2008). And in a study by 
Sagasad et al. (2007) they found increased percentage of granulocytes in salmon feed Bt -
maize. Observed effects on blood could therefore be caused by either DON or cry1Ab. An 
alteration in the granulocyte level could indicate an immune response in the blood. However, 
there were no significant differences between the amount of lymphocytes, granulocytes or 
monocytes amongst the different diets.  
 
Considering the results for the Bt- maize feeding trial collectively, with regards to the use of 
GM maize in aquaculture, low doses of naturally contaminated DON in combination with 
cry1Ab do not seem too affect fish performance or intestinal gene transcripts. As illustrated 
by the ELISA test, the cry1Ab will be destroyed during feed extrusion, and the natural DON 
contamination of 0.1 ppm seems too low to cause effects. 
A fact to be aware of when evaluating the results from the DON feeding trial is that there has 
been showed differences between naturally and synthetic DON in the feed (Trenholm et al., 
1994), where naturally contamination has shown to cause greater effects than synthetic DON. 
When the cereals are naturally contaminated, which would be the case in normal settings, 
there will also most likely be other mycotoxins present. Therefore, even though the DON 
levels for this trial are representative for natural circumstances, the same levels should also be 
investigated using ingredients which are naturally contaminated with fusarium spp.  
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5 CONCLUSION 
 
Based on the results from the two trials, have we come to the conclusion that;  
 
1) Cry1Ab in the Bt- maize feed do not significantly affect growth, intestinal mRNA or 
white blood cell composition when feed  to zebrafish,. The DON contamination of 0.1 
ppm in the Bt-maize feed does not affect the measured parameters either.  
2) The increasing concentrations of synthetic DON appear to be too low to significantly 
affect growth, intestinal mRNA or white blood cell differentiation in zebrafish. 
 
 
 
  
 
  
 
49 
 
References 
 
AGILENTECHNOLOGIES 2008. Electrophoresis and Bioanalyzer. In: UNIVERSIT, F. A. (ed.). Agilent 
technologies. 
AMUZIE, C. J., SHINOZUKA, J. & PESTKA, J. J. 2009. Induction of Suppressors of Cytokine Signaling by 
the Trichothecene Deoxynivalenol in the Mouse. Toxicological Sciences, 111, 277-287. 
ANDERSON, P. L., HELLMICH, R. L., SEARS, M. K., SUMERFORD, D. V. & LEWIS, L. C. 2004. Effects of 
Cry1Ab-expressing corn anthers on monarch butterfly larvae. Environmental Entomology, 33, 
1109-1115. 
ARMSTRONG, C. L., PARKER, G. B., PERSHING, J. C., BROWN, S. M., SANDERS, P. R., DUNCAN, D. R., 
STONE, T., DEAN, D. A., DEBOER, D. L., HART, J., HOWE, A. R., MORRISH, F. M., PAJEAU, M. E., 
PETERSEN, W. L., REICH, B. J., RODRIGUEZ, R., SANTINO, C. G., SATE, S. J., SCHULER, W., SIMS, 
S. R., STEHLING, S., TAROCHIONE, L. J. & FROMM, M. E. 1995. Field-Evaluation of European 
Corn-Borer Control in Progeny of 173 Transgenic Corn Events Expressing an Insecticidal 
Protein from Bacillus-Thuringiensis. Crop Science, 35, 550-557. 
AUMAITRE, L. A. 2002. New feeds from genetically modified plants: substantial equivalence, 
nutritional equivalence and safety for animals and animal products. Productions Animales, 
15, 97-108. 
BAKAN, B., MELCION, D., RICHARD-MOLARD, D. & CAHAGNIER, B. 2002. Fungal Growth and Fusarium 
Mycotoxin Content in Isogenic Traditional Maize and Genetically Modified Maize Grown in 
France and Spain. J Agric Food Chem, 50, 728-731. 
BAKKE-MCKELLEP, A. M., SANDEN, M., DANIELI, A., ACIERNO, R., HEMRE, G. I., MAFFIA, M. & 
KROGDAHL, A. 2008. Atlantic salmon (Salmo salar L.) parr fed genetically modified soybeans 
and maize: Histological, digestive, metabolic, and immunological investigations. Res Vet Sci, 
84, 395-408. 
BARTON, K. A., BINNS, A. N., MATZKE, A. J. M. & CHILTON, M. D. 1983. Regeneration of Intact 
Tobacco Plants Containing Full Length Copies of Genetically Engineered T-DNA, and 
Transmission of T-DNA to R1-Progeny. Cell, 32, 1033-1043. 
BENNETT, J. W. & KLICH, M. 2003. Mycotoxins. Clinical Microbiology Reviews, 16, 497-+. 
BETZ, F. S., HAMMOND, B. G. & FUCHS, R. L. 2000. Safety and advantages of Bacillus thuringiensis-
protected plants to control insect pests. Regulatory Toxicology and Pharmacology, 32, 156-
173. 
BIOMAR. Biosustain [Online]. Available: http://www.biomar.com/no/biosustain/ [Accessed 14.5 
2012]. 
BORUTOVA, R., FAIX, S., PLACHA, I., GRESAKOVA, L., COBANOVA, K. & LENG, L. 2008. Effects of 
deoxynivalenol and zearalenone on oxidative stress and blood phagocytic activity in broilers. 
Arch Anim Nutr, 62, 303-12. 
BRETZ, M., BEYER, M., CRAMER, B., KNECHT, A. & HUMPF, H. U. 2006. Thermal degradation of the 
Fusarium mycotoxin deoxynivalenol. J Agric Food Chem, 54, 6445-6451. 
BUSTIN, S. A. 2000. Absolute quantification of mRNA using real-time reverse transcription 
polymerase chain reaction assays. Journal of Molecular Endocrinology, 25, 169-193. 
BUSTIN, S. A. & NOLAN, T. 2004. Pitfalls of quantitative real-time reverse-transcription polymerase 
chain reaction. J Biomol Tech, 15, 155-66. 
CERA. 2009. MON810 [Online]. International life sience institute. Available: http://cera-
gmc.org/index.php?action=gm_crop_database&mode=ShowProd&data=MON810&frmat=SH
ORT [Accessed 15.5 2012]. 
CHOMCZYNSKI, P. & SACCHI, N. 1987. Single-step method of RNA isolation by acid guanidinium 
thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, 156-9. 
CHOMCZYNSKI, P. & SACCHI, N. 2006. The single-step method of RNA isolation by acid guanidinium 
thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc, 1, 581-5. 
 
  
 
50 
 
CHOWDHURY, E. H., KURIBARA, H., HINO, A., SULTANA, P., MIKAMI, O., SHIMADA, N., GURUGE, K. S., 
SAITO, M. & NAKAJIMA, Y. 2003. Detection of corn intrinsic and recombinant DNA fragments 
and Cry1Ab protein in the gastrointestinal contents of pigs fed genetically modified corn 
Bt11. Journal of Animal Science, 81, 2546-51. 
CHRISTOU, P. 1996. Transformation technology. Trends in Plant Science, 1, 423-431. 
CLASEN, P.-E. & BØRSUM, J. 2012. Mattilsynets overvåkingsprogram for mykotoksiner i 
næringsmidler i 2011. Veterinærinstituttets rapport-serie . . Oslo: Veterinærinstituttet. 
CORBIN, D. R. & KLEE, H. J. 1991. Agrobacterium-Tumefaciens-Mediated Plant Transformation 
Systems. Current Opinion in Biotechnology, 2, 147-152. 
CUMMINGS, D. E. 2006. Ghrelin and the short- and long-term regulation of appetite and body 
weight. Physiology &amp; Behavior, 89, 71-84. 
CYTOPATH. 2009. Making good blood smears [Online]. Available: 
http://www.cytopath.co.uk/smears.html [Accessed 10.2 2012]. 
DANICKE, S., GOYARTS, T., DOLL, S., GROVE, N., SPOLDERS, M. & FLACHOWSKY, G. 2006. Effects of 
the Fusarium toxin deoxynivalenol on tissue protein synthesis in pigs. Toxicology Letters, 165, 
297-311. 
DIETRICH, B., NEUENSCHWANDER, S., BUCHER, B. & WENK, C. 2012. Fusarium mycotoxin-
contaminated wheat containing deoxynivalenol alters the gene expression in the liver and 
the jejunum of broilers. Animal, 6, 278-291. 
DOWD, P. F. 2000. Indirect reduction of ear molds and associated mycotoxins in Bacillus thuringiensis 
corn under controlled and open field conditions: Utility and limitations. Journal of Economic 
Entomology, 93, 1669-1679. 
DREW, R. E., RODNICK, K. J., SETTLES, M., WACYK, J., CHURCHILL, E., POWELL, M. S., HARDY, R. W., 
MURDOCH, G. K., HILL, R. A. & ROBISON, B. D. 2008. Effect of starvation on transcriptomes of 
brain and liver in adult female zebrafish (Danio rerio). Physiological Genomics, 35, 283-295. 
DÖLL, S., BAARDSEN, G., KOPPE, W., STUBHAUG, I. & DÄNICKE, S. 2010. Effects of increasing 
concentrations of the mycotoxins deoxynivalenol, zearalenone or ochratoxin A in diets for 
Atlantic salmon (Salmo salar) on growth performance and health. The 14th International 
symposium on fish nutrition & feeding. Qingdao, China. 
ESPE, M., LEMME, A., PETRI, A. & EL-MOWAFI, A. 2006. Can Atlantic salmon (Salmo salar) grow on 
diets devoid of fish meal? Aquaculture, 255, 255-262. 
EU 2006. COMMISSION RECOMMENDATION of 17 August 2006 on the presence of deoxynivalenol, 
zearalenone, ochratoxin A, T-2 and HT-2 and fumonisins in 
products intended for animal feeding. Official Journal of the European Union. 
EWOS. 2011. Råvarer [Online]. Available: 
http://www.ewos.com/portal/wps/wcm/connect/ewosnorway/no/frontpage/om_ewos/Raa
varer [Accessed 16.3.2012 2012]. 
FAO 2010. THE STATE OF  WORLD FISHERIES AND AQUACULTUR. 
FICHCHANNEL.COM. 2010. Zebrafish [Online]. Available: http://www.fishchannel.com/images/fish-
news/zebra-danio-da-500.jpg [Accessed 16.6 2012]. 
GMO-COMPASS. 2010. Genetically modified plants: Global Cultivation Area Maize [Online]. Available: 
http://www.gmo-
compass.org/eng/agri_biotechnology/gmo_planting/341.genetically_modified_maize_global
_area_under_cultivation.html [Accessed 15.5 2012]. 
GOMEZ-REQUENI, P., CONCEICAO, L. E. C., JORDAL, A. E. O. & RONNESTAD, I. 2010. A reference 
growth curve for nutritional experiments in zebrafish (Danio rerio) and changes in whole 
body proteome during development. Fish Physiology and Biochemistry, 36, 1199-1215. 
GRIESSLER, K., RODRIGUES, I., HANDL, J. & HOFSTETTER, U. 2010. Occurrence of mycotoxins in 
Southern Europe. World Mycotoxin Journal, 3, 301-309. 
 
  
 
51 
 
HEINRICH, P. C., HORN, F., GRAEVE, L., DITTRICH, E., KERR, I., MULLER-NEWEN, G., GROTZINGER, J. & 
WOLLMER, A. 1998. Interleukin-6 and related cytokines: Effect on the acute phase reaction. 
Zeitschrift Fur Ernahrungswissenschaft, 37, 43-49. 
HELLMICH, R. L., SIEGFRIED, B. D., SEARS, M. K., STANLEY-HORN, D. E., DANIELS, M. J., MATTILA, H. R., 
SPENCER, T., BIDNE, K. G. & LEWIS, L. C. 2001. Monarch larvae sensitivity to Bacillus 
thuringiensis-purified proteins and pollen. Proc Natl Acad Sci U S A, 98, 11925-11930. 
HEMRE, G. I., SAGSTAD, A., BAKKE-MCKELLEP, A. M., DANIELI, A., ACIERNO, R., MAFFIA, M., 
FRØYSTAD, M., KROGDAHL, Å. & SANDEN, M. 2007. Nutritional, physiological, and 
histological responses in Atlantic salmon, Salmo salar L. fed diets with genetically modified 
maize. Aquaculture Nutrition, 13, 186-199. 
HERNÁNDEZ, P. P. & ALLENDE, M. L. 2008. Zebrafish (Danio rerio) as a model for studying the genetic 
basis of copper toxicity, deficiency, and metabolism. The American Journal of Clinical 
Nutrition, 88, 835S-839S. 
HILL, A. J., TERAOKA, H., HEIDEMAN, W. & PETERSON, R. E. 2005. Zebrafish as a model vertebrate for 
investigating chemical toxicity. Toxicological Sciences, 86, 6-19. 
HOEKEMA, A., HIRSCH, P. R., HOOYKAAS, P. J. J. & SCHILPEROORT, R. A. 1983. A Binary Plant Vector 
Strategy Based on Separation of Vir-Region and T-Region of the Agrobacterium-Tumefaciens 
Ti-Plasmid. Nature, 303, 179-180. 
HOOFT, J. M., ELMOR, A. E. H. I., ENCARNAÇÃO, P. & BUREAU, D. P. 2011. Rainbow trout 
(Oncorhynchus mykiss) is extremely sensitive to the feed-borne Fusarium mycotoxin 
deoxynivalenol (DON). Aquaculture, 311, 224-232. 
IMBEAUD, S., GRAUDENS, E., BOULANGER, V., BARLET, X., ZABORSKI, P., EVENO, E., MUELLER, O., 
SCHROEDER, A. & AUFFRAY, C. 2005. Towards standardization of RNA quality assessment 
using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res, 
33. 
JAIN, M., NIJHAWAN, A., TYAGI, A. K. & KHURANA, J. P. 2006. Validation of housekeeping genes as 
internal control for studying gene expression in rice by quantitative real-time PCR. Biochem 
Biophys Res Commun, 345, 646-651. 
JAMES, C. 2011. [The global status of the commercialized biotechnological/genetically modified 
crops: 2006]. Tsitol Genet, 41, 10-2. 
JAMES, C. 2012. Global Status of Commercialized Biotech/GM Crops: 2011. ISAAA Brief  Ithaca, NY.: 
ISAAA. 
KIMURA, S. H., IKAWA, M., ITO, A., OKABE, M. & NOJIMA, H. 2001. Cyclin G1 is involved in G2/M 
arrest in response to DNA damage and in growth control after damage recovery. Oncogene, 
20, 3290-300. 
KLEIN, T. M., FROMM, M., WEISSINGER, A., TOMES, D., SCHAAF, S., SLETTEN, M. & SANFORD, J. C. 
1988. Transfer of Foreign Genes into Intact Maize Cells with High-Velocity Microprojectiles. 
Proc Natl Acad Sci U S A, 85, 4305-4309. 
KLEIN, T. M., WOLF, E. D., WU, R. & SANFORD, J. C. 1987. High-Velocity Microprojectiles for 
Delivering Nucleic-Acids into Living Cells. Nature, 327, 70-73. 
KOUADIO, J. H., MOBIO, T. A., BAUDRIMONT, I., MOUKHA, S., DANO, S. D. & CREPPY, E. E. 2005. 
Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, 
zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology, 213, 56-65. 
KOZIEL, M. G., BELAND, G. L., BOWMAN, C., CAROZZI, N. B., CRENSHAW, R., CROSSLAND, L., 
DAWSON, J., DESAI, N., HILL, M., KADWELL, S., LAUNIS, K., LEWIS, K., MADDOX, D., 
MCPHERSON, K., MEGHJI, M. R., MERLIN, E., RHODES, R., WARREN, G. W., WRIGHT, M. & 
EVOLA, S. V. 1993. Field Performance of Elite Transgenic Maize Plants Expressing an 
Insecticidal Protein Derived from Bacillus-Thuringiensis. Bio-Technology, 11, 194-200. 
KRISHNASWAMY, R., DEVARAJ, S. N. & PADMA, V. V. 2010. Lutein protects HT-29 cells against 
Deoxynivalenol-induced oxidative stress and apoptosis: Prevention of NF-κB nuclear 
 
  
 
52 
 
localization and down regulation of NF-κB and Cyclo-Oxygenase – 2 expression. Free Radical 
Biology and Medicine, 49, 50-60. 
KROGDAHL, A., HEMRE, G. I. & MOMMSEN, T. P. 2005. Carbohydrates in fish nutrition: digestion and 
absorption in postlarval stages. Aquaculture Nutrition, 11, 103-122. 
KUBISTA, M., ANDRADE, J. M., BENGTSSON, M., FOROOTAN, A., JONÁK, J., LIND, K., SINDELKA, R., 
SJÖBACK, R., SJÖGREEN, B., STRÖMBOM, L., STÅHLBERG, A. & ZORIC, N. 2006. The real-time 
polymerase chain reaction. Molecular Aspects of Medicine, 27, 95-125. 
LANGSETH, W., BERNHOFT, A., RUNDBERGET, T., KOSIAK, B. & GAREIS, M. 1998. Mycotoxin 
production and cytotoxicity of Fusarium strains isolated from Norwegian cereals. 
Mycopathologia, 144, 103-113. 
LIESCHKE, G. J., OATES, A. C., CROWHURST, M. O., WARD, A. C. & LAYTON, J. E. 2001. Morphologic 
and functional characterization of granulocytes and macrophages in embryonic and adult 
zebrafish. Blood, 98, 3087-3096. 
LOVDATA. 2001. Forskrift om innesluttet bruk av genmodifiserte mikroorganismer [Online]. 
lovdata.no. Available: http://www.lovdata.no/cgi-
wift/wiftldles?doc=/app/gratis/www/docroot/ltavd1/filer/sf-20011221-
1600.html&emne=gmo*%20%2b%20definisjon*&#2 [Accessed 30.5 2012]. 
MAGG, T., MELCHINGER, A. E., KLEIN, D. & BOHN, M. 2002. Relationship between European corn 
borer resistance and concentration of mycotoxins produced by Fusarium spp. in grains of 
transgenic Bt maize hybrids, their isogenic counterparts, and commercial varieties. Plant 
Breeding, 121, 146-154. 
MCCLINTOCK, J. T., SCHAFFER, C. R. & SJOBLAD, R. D. 1995. A Comparative Review of the Mammalian 
Toxicity of Bacillus Thuringiensis-Based Pesticides. Pesticide Science, 45, 95-105. 
MCMULLEN, M. P., ENZ, J., LUKACH, J. & STOVER, R. 1997. Environmental conditions associated with 
Fusarium head blight epidemics of wheat and barley in the Northern Great Plains, North 
America. Cereal Research Communications, 25, 777-778. 
MESNAGE, R., CLAIR, E., GRESS, S., THEN, C., SZÉKÁCS, A. & SÉRALINI, G. E. 2012. Cytotoxicity on 
human cells of Cry1Ab and Cry1Ac Bt insecticidal toxins alone or with a glyphosate-based 
herbicide. Journal of Applied Toxicology, n/a-n/a. 
MOON, Y. & PESTKA, J. J. 2003. Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin 
(deoxynivalenol) in vitro and in vivo. Toxicol Appl Pharmacol, 187, 80-88. 
MUNKVOLD, G. P., HELLMICH, R. L. & SHOWERS, W. B. 1997. Reduced Fusarium ear rot and 
symptomless infection in kernels of maize genetically engineered for European corn borer 
resistance. Phytopathology, 87, 1071-1077. 
NGUYEN, H. T. & JEHLE, J. A. 2007. Quantitative analysis of the seasonal and tissue-specific 
expression of Cry1Ab in transgenic maize Mon810. Journal of Plant Diseases and Protection, 
114, 82-87. 
NOLAN, T., HANDS, R. E. & BUSTIN, S. A. 2006. Quantification of mRNA using real-time RT-PCR. Nat 
Protoc, 1, 1559-1582. 
OSTRY, V., OVESNA, J., SKARKOVA, J., POUCHOVA, V. & RUPRICH, J. 2010. A review on comparative 
data concerning &lt;i&gt;Fusarium mycotoxins in Bt maize and non-Bt isogenic maize. 
Mycotoxin Research, 26, 141-145. 
OSWALD, I. P., MARIN, D. E., BOUHET, S., PINTON, P., TARANU, I. & ACCENSI, F. 2005. 
Immunotoxicological risk of mycotoxins for domestic animals. Food Additives and 
Contaminants, 22, 354-360. 
OYEDOTUN, K. S. & LEMIRE, B. D. 2004. The Quaternary Structure of the Saccharomyces cerevisiae 
Succinate Dehydrogenase. Journal of Biological Chemistry, 279, 9424-9431. 
PAPST, C., UTZ, H. F., MELCHINGER, A. E., EDER, J., MAGG, T., KLEIN, D. & BOHN, M. 2005. Mycotoxins 
produced by Fusarium spp. in isogenic Bt vs. non-Bt maize hybrids under European corn 
borer pressure. Agronomy Journal, 97, 219-224. 
 
  
 
53 
 
PEARSON, G., ROBINSON, F., BEERS GIBSON, T., XU, B.-E., KARANDIKAR, M., BERMAN, K. & COBB, M. 
H. 2001. Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological 
Functions. Endocrine Reviews, 22, 153-183. 
PEEL, M. D. 2001. A Basic Primer on Biotechnology [Online]. NDSU Extension Service. Available: 
http://www.ag.ndsu.edu/pubs/plantsci/crops/a1219w.htm  
PESTKA, J. J. 2008. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food 
Additives and Contaminants Part a-Chemistry Analysis Control Exposure & Risk Assessment, 
25, 1128-1140. 
PESTKA, J. J., ZHOU, H.-R., MOON, Y. & CHUNG, Y. J. 2004. Cellular and molecular mechanisms for 
immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. 
Toxicology Letters, 153, 61-73. 
PIETSCH, C., BUCHELI, T. D., WETTSTEIN, F. E. & BURKHARDT-HOLM, P. 2011. Frequent biphasic 
cellular responses of permanent fish cell cultures to deoxynivalenol (DON). Toxicol Appl 
Pharmacol, 256, 24-34. 
PINTON, P., ACCENSI, F., BEAUCHAMP, E., COSSALTER, A.-M., CALLU, P., GROSJEAN, F. & OSWALD, I. 
P. 2008. Ingestion of deoxynivalenol (DON) contaminated feed alters the pig vaccinal 
immune responses. Toxicology Letters, 177, 215-222. 
PITT, J. I., BASILICO, J. C., ABARCA, M. L. & LOPEZ, C. 2000. Mycotoxins and toxigenic fungi. Medical 
Mycology, 38, 41-46. 
PRELUSKY, D. B., GERDES, R. G., UNDERHILL, K. L., ROTTER, B. A., JUI, P. Y. & TRENHOLM, H. L. 1994. 
Effects of low-level dietary deoxynivalenol on haematological and clinical parameters of the 
pig. Nat Toxins, 2, 97-104. 
RICHARD, J. L. 2007. Some major mycotoxins and their mycotoxicoses—An overview. International 
Journal of Food Microbiology, 119, 3-10. 
ROBBANA‐BARNAT, S., LORIDON‐ROSA, B., COHEN, H., LAFARGE‐FRAYSSINET, C., NEISH, G. A. & 
FRAYSSINET, C. 1987. Protein synthesis inhibition and cardiac lesions associated with 
deoxynivalenol ingestion in mice. Food Additives and Contaminants, 4, 49-56. 
ROTTER, B. A. 1996. Invited Review: TOXICOLOGY OF DEOXYNIVALENOL (VOMITOXIN). Journal of 
Toxicology and Environmental Health, 48, 1-34. 
ROTTER, B. A., THOMPSON, B. K., LESSARD, M., TRENHOLM, H. L. & TRYPHONAS, H. 1994. Influence 
of Low-Level Exposure to Fusarium Mycotoxins on Selected Immunological and 
Hematological Parameters in Young Swine. Fundamental and Applied Toxicology, 23, 117-
124. 
SAGSTAD, A., SANDEN, M., HAUGLAND, O., HANSEN, A. C., OLSVIK, P. A. & HEMRE, G. I. 2007. 
Evaluation of stress- and immune-response biomarkers in Atlantic salmon, Salmo salar L., fed 
different levels of genetically modified maize (Bt maize), compared with its near-isogenic 
parental line and a commercial suprex maize. J Fish Dis, 30, 201-12. 
SANDEN, M., BERNTSSEN, M. H., KROGDAHL, A., HEMRE, G. I. & BAKKE-MCKELLEP, A. M. 2005. An 
examination of the intestinal tract of Atlantic salmon, Salmo salar L., parr fed different 
varieties of soy and maize. J Fish Dis, 28, 317-30. 
SANDEN, M., JØRGENSEN, S., HEMRE, G.-I., ØRNSRUD, R. & SISSENER, N. 2012. Zebrafish (Danio 
rerio) as an aquatic model for investigating dietary toxic effects of deoxynivalenol 
contamination in aquaculture feeds. 
SANDEN, M., KROGDAHL, A., BAKKE-MCKELLEP, A. M., BUDDINGTON, R. K. & HEMRE, G. I. 2006. 
Growth performance and organ development in Atlantic salmon, Salmo salar L. parr fed 
genetically modified (GM) soybean and maize. Aquaculture Nutrition, 12, 1-14. 
SHIMADA, N., MIYAMOTO, K., KANDA, K. & MURATA, H. 2006. Bacillus thuringiensis insecticidal 
Cry1ab toxin does not affect the membrane integrity of the mammalian intestinal epithelial 
cells: An in vitro study. In Vitro Cell Dev Biol Anim, 42, 45-9. 
 
  
 
54 
 
SISSENER, N. H., HEMRE, G. I., LALL, S. P., SAGSTAD, A., PETERSEN, K., WILLIAMS, J., ROHLOFF, J. & 
SANDEN, M. 2011a. Are apparent negative effects of feeding GM MON810 maize to Atlantic 
salmon, Salmo salar, caused by confounding factors? Br J Nutr, 106, 42-56. 
SISSENER, N. H., JOHANNESSEN, L. E., HEVROY, E. M., WIIK-NIELSEN, C. R., BERDAL, K. G., 
NORDGREEN, A. & HEMRE, G. I. 2010. Zebrafish ( Danio rerio) as a model for investigating the 
safety of GM feed ingredients (soya and maize); performance, stress response and uptake of 
dietary DNA sequences. Br J Nutr, 103, 3-15. 
SISSENER, N. H., SANDEN, M., KROGDAHL, A., BAKKE, A. M., JOHANNESSEN, L. E. & HEMRE, G. I. 
2011b. Genetically modified plants as fish feed ingredients. Canadian Journal of Fisheries and 
Aquatic Sciences, 68, 563-574. 
SKRETTING 2010. Fiskefôr. In: NORWAY, S. (ed.). 
SMITH, J. E., SOLOMONS, G., LEWIS, C. & ANDERSON, J. G. 1995. Role of mycotoxins in human and 
animal nutrition and health. Natural Toxins, 3, 187-192. 
SOLDANI, C. & SCOVASSI, A. I. 2002. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An 
update. Apoptosis, 7, 321-328. 
STELLA G, U. 2000. The impact of genetic modification of human foods in the 21st century: A review. 
Biotechnology Advances, 18, 179-206. 
TIEMANN, U., VIERGUTZ, T., JONAS, L. & SCHNEIDER, F. 2003. Influence of the mycotoxins α- and β-
zearalenol and deoxynivalenol on the cell cycle of cultured porcine endometrial cells. 
Reproductive Toxicology, 17, 209-218. 
TORSTENSEN, B. E., ESPE, M., SANDEN, M., STUBHAUG, I., WAAGBØ, R., HEMRE, G. I., FONTANILLAS, 
R., NORDGARDEN, U., HEVRØY, E. M., OLSVIK, P. & BERNTSSEN, M. H. G. 2008. Novel 
production of Atlantic salmon (Salmo salar) protein based on combined replacement of fish 
meal and fish oil with plant meal and vegetable oil blends. Aquaculture, 285, 193-200. 
TRENHOLM, H. L., THOMPSON, B. K., FOSTER, B. C., CHARMLEY, L. L., HARTIN, K. E., COPPOCK, R. W. 
& ALBASSAM, M. A. 1994. Effects of feeding diets containing Fusarium (naturally) 
contaminated wheat or pure deoxynivalenol (DON) in growing pigs. Canadian Journal of 
Animal Science, 74, 361-369. 
VAN DER SAR, A. M., APPELMELK, B. J., VANDENBROUCKE-GRAULS, C. M. J. E. & BITTER, W. 2004. A 
star with stripes: zebrafish as an infection model. Trends in Microbiology, 12, 451-457. 
VANGUILDER, H. D., VRANA, K. E. & FREEMAN, W. M. 2008. Twenty-five years of quantitative PCR for 
gene expression analysis. Biotechniques, 44, 619-626. 
VESONDER, R. F., CIEGLER, A. & JENSEN, A. H. 1973. Isolation of the emetic principle from Fusarium-
infected corn. Appl Microbiol, 26, 1008-10. 
VKM. 2012. Helserisikovurdering av cry-proteiners adjuvanseffekter. [Online]. Norwegian Sientific 
committee for food safety. Available: http://www.vkm.no/dav/d6991c1718.pdf [Accessed 
30.5 2012]. 
WALGREENS. 2011. White blood cell count [Online]. Available: 
http://www.walgreens.com/marketing/library/contents.jsp?docid=100151&doctype=3 
[Accessed 16.5 2012]. 
WALSH, M. C., BUZOIANU, S. G., GARDINER, G. E., REA, M. C., ROSS, R. P., CASSIDY, J. P. & LAWLOR, P. 
G. 2012. Effects of short-term feeding of Bt MON810 maize on growth performance, organ 
morphology and function in pigs. Br J Nutr, 107, 364-71. 
WATANABE, T. 2002. Strategies for further development of aquatic feeds. Fisheries Science, 68, 242-
252. 
WILSON, J. M., BUNTE, R. M. & CARTY, A. J. 2009. Evaluation of Rapid Cooling and Tricaine 
Methanesulfonate (MS222) as Methods of Euthanasia in Zebrafish (Danio rerio). Journal of 
the American Association for Laboratory Animal Science, 48, 785-789. 
WOODWARD, B., YOUNG, L. G. & LUN, A. K. 1983. Vomitoxin in diets for rainbow trout (Salmo 
gairdneri). Aquaculture, 35, 93-101. 
 
  
 
55 
 
YOUNG, L. G., MCGIRR, L., VALLI, V. E., LUMSDEN, J. H. & LUN, A. 1983. Vomitoxin in corn fed to 
young pigs. Journal of Animal Science, 57, 655-64. 
 
 
  
 
  
 
56 
 
Appendix  
 
Appendix I: Feed ingredients 
The specifications of the ingredients for the two different feeding trials. All ingredients are the 
same except that for the Bt -maize trial was not potato starch (5) or DON (10) added.   
1Casein from bovine milk (Sigma Life Science, St Louis, MO, USA) 
 
2 Gelatin from porcine skin (Fluka BioChemica, Buchs, Switzerland) 
 
3 Möller’s Tran, Axellus AS, Oslo, Norway 
 
4 Eldorado, Oslo, Norway 
 
5 Potato starch, Hoff Norske, Gjøvik, Norway 
 
6 Refined, Alfa Aesar, Karlsruhe, Germany 
 
7 Mineral mix; 66% dicalcium phosphate dehydrate, 0.014% cobalt chloride hexahydrate, 
0.04% copper sulphate, 30% potassium sulphate, 0.1% potassium iodide, 2% magnesium 
sulphate heptahydrate, 0.1% manganese sulphate, 5.7% sodium chloride, 0.01% sodium 
selenite, 1% zinc sulphate heptahydrate, 1% iron sulphate heptahydrate 
 
8 Vitamin mix; 0.1% vitamin A (500.000 IU), 0.04% vitamin D3 (500.000 IU), 2% vitamin E, 
0.1% vitamin K, 4.3% vitamin C, 40% choline, 0.15% thiamine, 0.19% riboflavin, 0.2% 
pyridoxine, 2% niacin, 4% inositol, 0.05% folic acid, 0.6% calcium panthotenat, 0.75% 
biotin, 0.3% cobalamin, 45.2% casein salt 
 
9 AA mix; 4.3% taurine, 21.4% aspartic acid, 6.4% threonine, 8.5% glycine, 15.2% alanine,   
4.3% valine, 5.8% methionine, 4.3% isoleucine, 8.5% leucine, 6.4% lysine, 8.5% arginine, 
6.4% tryphtophan  
 
10 Synonyms; 3α,7α,15-Trihydroxy-12,13-epoxytrichothec-9-en-8-one, Vomitoxin. Empirical 
formula, C15H20O6 (Sigma Life Science, St Louis, MO, USA)  
 
11 Maize event mon810 produced in spain 2010/2011 
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Appendix II: RNA extraction 
Table II A Chemicals and reagents used for RNA extraction. 
Product name  Vendor  
Trizol  Invitrogen art.nr. 15596-026, USA  
Chloroform  Merck, Germany  
Isopropanol  Arcus, Norway  
Ethanol  Arcus, Norway  
DEPC (Diethyl pyrocarbonate)  Sigma art.nr. F32490  
RNase free ddH2O  MilliQ Gradient, Lab-tec, Norway  
RNase Zap  Sigma art.nr. R2020, USA  
 
Appendix III: Agilent 2100 Bioanalyzer  
Table III A Chemicals and reagents used for RNA quality measurements by the Agilent 2100 
Bioanalyzer. 
Product name  Vendor  
RNA 6000 Nano Labchip kit  Agilent Technologies art.nt.5065-4476  
RNA 6000 Ladder  Ambion art.nr. 7152  
RNase free ddH2O  MilliQ Gradient, Lab-tec, Norway  
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Appendix III Figure A: An example of how the results from the agilent bioanalyzer are 
presented. The RIN are circled for the three firth graphs.  
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Appendix IV: RT-reaction  
Table IV A Chemicals and reagents used in RT-reaction . 
Product name  Vendor  
TaqMan RT buffer 10X  Applied Biosystems art.nr. N808 0234  
25 mM Magnesium chloride  Applied Biosystems art.nr. N808 0234  
10 mM deoxyNTPs  Applied Biosystems art.nr. N808 0234  
50 μM Oligo d(T)16 primer  Applied Biosystems art.nr. N808 0234  
RNase inhibitor (20 U/μl)  Applied Biosystems art.nr. N808 0234  
Multiscribe reverse transcriptase (50 U/ μl)  Applied Biosystems art.nr. N808 0234  
RNase free ddH2O  MilliQ Gradient, Lab-tec, Norway  
 
Table IV B  RT- reaction mix for a 30 μl reaction mix . 
Properties  Reagent  Amount (μl) for 96 wells  
Reagents without enzymatic 
properties  
 
RNase free water  267 
TaqMan RT buffer 10X  150 
25 mM Magnesium chloride  330 
10 mM deoxyNTPs  300 
50 μM Oligo d(T)16 primer  75 
Enzymes  RNase inhibitor (20 U/μl)  
30 
Multiscribe reverse transcriptase (50 U/ μl)  50,1 
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Table IV C Reverse Transcriptase reaction conditions . 
Step  Temperature (°C)  Time (minutes)  
Incubation  25  10  
Reverse Transcriptase  48  60  
Reverse Transcriptase 
inactivation  
95  5  
End  4  ∞  
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Appendix V: One step test of primers 
Table V A: Amount of reagents for testing of primers. 
Reagent 
 
Volume Final concentration 
5 x QIAGEN One step RT-PCR buffer 
 
10 µl 1 X 
dNTP mix 
 
10 µl  5 X 
RNase fritt vann 
 
19 µl ( final volume 50 µl)  
Primer forward 
 
3 µl 0.6 µM 
Primer reverse 
 
3 µl 0.6 µM 
QIAGEN One step RT-PCR MIX 
 
2 µl  
RNA template 
 
1 µl  
 
Table V B: RT-PCR cycle for One step gene test. 
Proses Time  Temperature 
Reverse 
transcriptase  
30 min  50C  
PCR activating  15 min  95C  
3 step cycle 
Denaturizing  45 sek (30-60)  94C  
Annealing  45 sek (30-60)  55C (50-68)  
Extension  1 min  72 C  
Number of cycles  33 (25-40)  
Final extension  10 min  72C  
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Appendix VI : Quantitative Real-Time PCR 
Table VI A Chemicals and reagents used for real-time PCR. 
Product name  Vendor  
SYBR GREEN Master  Roche, Norway  
Primer   Invitrogen Ltd, UK  
RNase free ddH2O  MilliQ Gradient, Lab-tec, Norway  
 
Table VI B: SYBR GREEN reaction mix for Light Cycler 480 (10 μl reaction). 
Reagent  Volume (μl) 
RNase free water  331 
Forward primer  11.4 
Reverse primer   11.4 
SYBR GREEN Master  570 
 
